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ABSTRACT 
 The skeleton is one of the most widely explored organs for defining mesenchymal 
stem/progenitor cell (MSC) populations, and there is significant interest in MSCs for 
their potential in novel and potentially curative therapies for a variety of musculoskeletal 
disorders. The skeleton is a highly dynamic tissue and MSCs function as a reservoir of 
new cellular material to support skeletal growth, turnover, and repair. Using a 
Hoxa11eGFP reporter allele, recent work demonstrated Hox11-expressing cells in the 
adult skeleton are identified as an MSC-enriched population in the bone marrow and on 
the cortical bone surfaces. In fact, at all stages examined Hoxa11eGFP-expression is 
excluded from all differentiated skeletal cell types. Developmentally, Hox genes are 
critically important patterning regulators and function regionally along the axes of the 
mammalian skeleton. The Hox11 genes specifically function to pattern the lumbar spine 
and zeugopod region (radius/ulna and tibia/fibula) of the limb. In addition to classical 
functions for Hox genes during development, ongoing work has revealed continuing 
functions for Hox11 during skeletal growth and adult injury repair. Given the continuum 
of Hox11-expression in undifferentiated stromal cells and the genetic evidence for Hox11 
function at all stages, I investigated the possibility that Hox11-expression may identify a 
skeletal progenitor population throughout the life of the animal. These studies aimed to 
understand the lineage-relationship of Hox11-expressing stromal cells from embryonic to 
adult stages and to test the skeletal progenitor potential of this population over time. 
The first evidence to support the hypothesis that Hox11-expressing cells are 
skeletal progenitors at all stages, was flow cytometry data demonstrating that 
Hoxa11eGFP-expressing cells co-express adult MSC markers PDGFRα/CD51 and Leptin 
Receptor (LepR) throughout life, beginning from embryonic stages. To rigorously 
investigate the skeletal progenitor potential of this population in vivo, I generated a 
Hoxa11-CreERT2 allele by Cas9/CRISPR genetic engineering. I demonstrate that 
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Hoxa11-lineage marked cells are multi-potent in vivo and contribute to all mesenchymal 
cell types of the skeleton; cartilage, bone, and adipose. Hoxa11-lineage marked cells 
continue to contribute to new skeletal cells out to at least one year of age. In addition to 
giving rise to the skeleton, Hoxa11-lineage marked stromal cells persist within the bone 
marrow and on the bone surfaces throughout life, even from embryonic stages. Lineage-
marked stromal cells co-express MSC markers PDGFRα/CD51 and LepR and continue to 
express Hoxa11eGFP at all time points. The expression of Hoxa11eGFP within Hoxa11-
lineage marked MSCs throughout life, and the continuous contribution to new skeletal 
cells provides evidence that Hox11-expressing MSCs are self-renewing skeletal stem 
cells. These data reconcile conflicting reports in the field regarding when MSCs arise and 
provide definitive genetic evidence for an embryonic, perichondrial origin for life-long 
skeletal stem cells.
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CHAPTER I 
Introduction 
Hox genes as patterning regulators of embryonic development 
The Hox genes are a family of highly evolutionarily conserved homeodomain-
containing transcription factors that pattern the developing embryo as first described in 
the fruit fly, Drosophila melanogaster. The first spontaneous homeotic mutations in the 
fly body plan, where one segment is transformed to acquire the identity of another, were 
described in the late nineteenth and early twentieth century [1, 2]. Seminal work by E.B. 
Lewis and T.C. Kaufman described a series of ordered homeodomain containing genes 
that had the capacity to regulate segment identity [Figure 1.1] [3-5]. They determined that 
the positional arrangement of the genes within the Drosophila homeotic complex (HOM-
C) was directly correlated with their functional domain along the anterior to posterior 
(AP) axis, a concept termed colinearity [3-5]. Hox genes have been conserved throughout 
all bilaterians from flies to rodents to humans, and the clustered organization of these 
genes has been maintained throughout evolution [6]. Through multiple genomic 
duplication events, the number of Hox genes in all mammals, including mouse and 
human, has increased resulting in four chromosomal clusters, HoxA, HoxB, HoxC, and 
HoxD [Figure 1.1] [7]. Teleost fish represent a unique example of additional duplications 
and possess 7 or more Hox clusters [8-10]. 
The four mammalian clusters contain a total of 39 Hox genes [Figure 1.1] [11, 
12]. Correlation of sequence similarity, position within the cluster, and expression 
domains has permitted further organization of these genes into 13 paralogous groups, 
Hox1-Hox13, positioned 3’ to 5’ along the chromosome, although no cluster contains the 
full complement of 13 Hox genes [13]. The highly conserved features of paralogous Hox  
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Figure 1.1: Schematic of Drosophila HOM-C complexes and mammalian Hox genes 
clusters. Colored boxes represent linear arrangement of genes 3’ to 5’ (left to right) along 
the chromosome. Color-coding depicts orthologous relationships between Drosophila 
and mammalian Hox genes, and paralogous relationships within the mammalian Hox 
clusters.  
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genes results in substantial functional redundancy between members. Loss-of-function 
mutations in a single Hox paralog generally results in a mild or no phenotype due to the 
redundant functions of the remaining paralogs [14-16]. In many cases, assessing Hox 
gene function has required combining loss-of-function mutations in multiple or all 
members within the paralogous groups [14-29]. 
Hox paralogs that are located at the most 3’ end of the cluster (Hox1 and Hox2) 
are expressed earliest in the anterior embryo with next most paralogous genes being 
expressed progressively later with more posterior domains [30-37]. Collinearity is a 
property of Hox genes that has been preserved throughout evolution of the cluster and is 
predicted to be one of the strongest drivers protecting the clustering of Hox genes within 
the genome [6, 7, 11]. It is perhaps impossible to determine whether cis-collinearity, 
clustering of Hox genes along the chromosome, drove the development of spatial and 
temporal collinearity in expression or vice versa, however it is clear that these two 
properties are intimately linked [7]. Interestingly, vertebrates appear to have the tightest 
organization of the Hox clusters suggesting evolutionary pressure to maintain and refine 
this configuration [7].  
 Collinear Hox gene expression correlates with changes in vertebral morphology 
along the AP axis of the body [38]. The result is overlapping paralog expression domains 
that are increasingly posteriorly restricted. This combinatorial code of Hox expression 
along the AP axis results in vertebrae morphology being determined by patterning 
information from multiple Hox genes, usually two paralogous groups [39-42]. With loss-
of-function mutations in an entire paralogous group, the region that normally receives 
this input is patterned by the remaining Hox genes expressed in that region. Generally, 
the region most affected by paralogous loss-of-function mutations corresponds to the 
anterior limit of expression of the lost Hox genes [14-16]. In the majority of cases, this 
leads to anterior homeotic transformations in which the vertebrae assume a more anterior 
morphology [14-16, 26]. For example, the Hox10 genes normally pattern the lumbar 
region of the spine, however with complete paralogous loss-of-function of Hox10 genes, 
the lumbar vertebrae acquire a thoracic-like morphology with rib-like projections 
extending throughout the lumbosacral region of the spine [16]. Similar homeotic 
transformations are observed in complete Hox11 mutants where the sacral spinal region is 
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transformed to a lumbar-like morphology [16]. The function of Hox genes in determining 
segment identity was also demonstrated in the gain-of-function scenario where ectopic 
expression of Hox10 genes in the thoracic region of the spine suppressed normal rib 
formation [43]. Thus, Hox genes are essential regulators of axial patterning and skeletal 
morphology. 
  In addition to their functions in the axial skeleton, the posterior Hox paralogs 
(Hox9-13) have been co-opted to pattern the limb skeleton along the proximodistal (PD) 
axis. The vertebrate limb can be divided into three segments along this axis: the proximal 
stylopod (humerus/femur), the medial zeugopod (radius and ulna/tibia and fibula), and 
the distal autopod (carpals and metacarpals/tarsals and metatarsals). Each region of the 
limb is patterned by specific Hox paralogs; Hox9 and Hox10 genes pattern the stylopod, 
Hox11 genes pattern the zeugopod, and Hox13 genes pattern the autopod [16, 22, 23]. 
Additionally, the posterior HoxA and HoxD clusters are expressed in both the forelimb 
and the hindlimb, while the HoxC cluster is only expressed in the hindlimb [16, 21, 44]. 
Hox loss-of-function phenotypes in the limb cannot be described as classical homeotic 
transformations as observed in the axial skeleton. In the limb, there is little overlap of 
paralog expression and Hox mutants exhibit a complete, regional loss of patterning 
information within the segment in which they are expressed. For example, loss of Hox10 
paralogs results in severe mis-patterning of the stylopod while Hox11 mutants have 
severe zeugopod mis-patterning [16, 21, 22]. Hox13 mutants exhibit a complete loss of 
all autopod skeletal elements [23]. It is important to note that specification of the skeletal 
elements, with respect to position and number is normal and it is the subsequent 
elaboration of that pattern that is disrupted with loss of Hox function. In fact, with loss of 
the complete posterior HoxA and HoxD genes in the limb bud, early specification of the 
proximal skeletal elements still occurs [45]. These data establish the posterior Hox genes 
as critical regulators of organization of the limb skeletal structures. Despite substantial 
genetic evidence establishing the importance of Hox genes in skeletal patterning, 
remarkably little is understood regarding the molecular or cellular mechanisms of Hox 
function. 
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Development of the Musculoskeletal System 
 Origin of the musculoskeletal tissues 
The limb musculoskeletal system is composed of mesodermal tissue that is 
derived from two distinct embryonic compartments [Figure 1.2]. The lateral plate 
mesoderm gives rise to the limb bud itself and all the cartilage and tendon precursors are 
derived from this compartment [46, 47]. In contrast, muscle precursors differentiate from 
the dermomyotomal compartment of the axial somites adjacent to the limb field and 
migrate into the limb bud to form the limb musculature [48-51]. Limb development 
involves highly coordinated differentiation and patterning of all three tissues. 
In mouse, the forelimb bud emerges at embryonic day 9 (E9.0) from the lateral 
plate mesoderm on either side of the embryo with the hindlimb bud emerging 
approximately a half a day later. The skeletal pattern of the limb arises as Sox9-positive 
cartilage precursors condense centrally within the limb bud mesenchyme from proximal 
(stylopod, ~E10.0) to distal (autopod, ~E11.5) [52-55]. Concurrently, muscle precursor 
cells delaminate from the ventrolateral dermomyotome of the axially-located somites 
adjacent to the limb bud and migrate into the limb as dorsal and ventral masses, where 
they continue to proliferate, aggregate, and differentiate into muscle tissue [48, 56]. The 
tendon primordia and the other connective tissues of the limb arise from within the limb 
lateral plate mesoderm and align between the muscle masses and the skeletal elements 
[57-59]. The transcription factor Scleraxis (Scx) is the earliest known tendon marker and 
can be detected in the limb buds by E10.5, however an overt tendon pattern is not 
observed until E12.5 [58-60]. The dorsal and ventral muscle bundles segregate into 
individual anatomical groups as muscle connective tissue cells align along future sites of 
splitting and initiate cell death [57, 61, 62]. This process generally proceeds in a proximal 
to distal and dorsal to ventral fashion along the limb axes. Bone, tendon, and muscle 
precursors undergo concurrent differentiation and patterning in a highly coordinated 
fashion to allow for proper integration of the tissues into a functional musculoskeletal 
unit. The mechanisms governing these integration events are an area of active study. 
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Figure 1.2: Limb musculoskeletal tissues are derived from two distinct mesodermal 
compartments. Tendon (green) and chondrocyte (red) precursors are derived from the 
lateral plate mesoderm within the limb bud, and tendon primordia arise adjacent to the 
centrally localized chondrocyte condensations. Muscle precursors (purple) delaminate 
from the ventral somite adjacent to the limb and migrate into the limb bud as dorsal and 
ventral muscle masses.  
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Integration of the Musculoskeletal Unit 
 Much is understood regarding the development of the three main tissues of the 
skeleton individually, but only recently has progress been made in understanding how 
these tissues are integrated into a functional musculoskeletal unit. For proper function, 
the appropriate muscles must be precisely connected to the bony elements, via tendon, to 
allow for locomotion. At the earliest stages of limb development, specification and 
patterning of cartilage, tendon, and muscle tissues appear to be tissue autonomous and 
each of these tissues can initially develop in the absence of the others [47, 48, 63]. As 
development proceeds, tissue-tissue interactions are required for the maintenance and 
continued maturation of each component. 
Muscle precursors themselves have no intrinsic or pre-determined patterning 
information. Classical chick-quail graft experiments, where somites outside the normal 
limb region are grafted into the axial region adjacent to the limb, demonstrated that 
muscles from any somite are capable of migrating into the limb and forming normal limb 
musculature [48, 49]. Retroviral-labeling of myogenic progenitors migrating into the 
developing limb field showed that individual myoblasts are not biased towards 
contributing to any specific muscle bundle [64]. Additionally, if tendon primordia are 
surgically removed, muscle progenitors still migrate into the limb bud mesenchyme and 
are able to undergo maturation demonstrating that differentiation of muscle tissue is 
autonomous and does not require signals from the tendon [57]. However, following 
removal of tendon primordia, muscle patterning is entirely disrupted.  
The entirety of the muscle patterning information is contained within the muscle 
connective tissue elements of the limb. Prior to muscle invasion, muscle connective tissue 
fibroblasts form a muscle pre-pattern that functions to sub-divide the dorsal and ventral 
muscle streams into individual muscle groups [65]. Muscle connective tissue fibroblasts 
are marked by the transcription factor Tcf4 and can be observed as early as E12.5 in the 
developing limb bud [65, 66]. Tcf4-positive fibroblasts are intimately associated with the 
myofibers of the limb musculature during development and remain associated throughout 
life [66]. There is evidence that Tcf4-positive connective tissue fibroblasts function as an 
extrinsic source of signals to regulate muscle myofiber type and myofiber maturation 
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[66]. In addition to being a marker of the muscle connective tissue, Tcf4 appears to have 
a functional role in regulating muscle patterning. Tcf4 loss-of-function disrupts several 
aspects of muscle patterning resulting in abnormal muscle splitting and truncation of 
several muscles, as well as mispatterning of the sites of muscle integration with the bone 
[65, 66]. Collectively, these data establish the importance of the connective tissue 
elements, including tendon, in patterning the individual muscle bundles and also 
regulating the fiber type composition of the individual muscles. 
Initial tendon patterning events are tissue autonomous, however continued 
maintenance of tendon progenitors requires interactions with the muscle and the skeletal 
elements. Careful examination of muscle-less and skeletal-less limb models revealed that 
tendon requirements for tissue-tissue interactions differs along the proximal to distal axis 
of the limb. In the absence of muscle, proximal tendon progenitors are progressively lost 
while tendon differentiation occurs normally in the distal autopod region [57, 67, 68]. In 
contrast, if skeletal formation is inhibited through conditional loss of Sox9 in the limb 
bud, the muscle and tendon of the proximal elements occurs normally while autopod 
tendons are completely absent [60]. Tendon progenitor induction and skeletal 
condensation are tightly linked as increases or decreases in the number of digits results in 
a corresponding increase or decrease in formation of the associated tendons [69]. These 
data suggest a requirement for muscle-tendon interactions in the proximal limb and 
cartilage-tendon interactions in the distal limb for tendon tissue maintenance. 
Interestingly, it is still unclear whether physical interactions or signaling between tissues 
is required for tendon maintenance. 
The differences between proximal and distal tendon maturation led to a re-
examination of how tendons develop, particularly tendons that span the 
zeugopod/autopod boundary. There are several long tendons that originate within the 
zeugopod but anchor to the skeleton within the autopod which appeared inconsistent with 
data indicating differing requirements for tendon within these two regions. Careful 
examination of tendon development during the transition from the muscle-independent 
phase to the muscle-dependent phase revealed a modular mechanism of tendon 
development [60]. Initially, short tendon progenitors integrate with the proximal and 
distal ends of the individual muscle groups. As limb outgrowth continues, the short 
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tendons integrate with the skeletal elements at the proximal end of the muscle and form 
connections with their counter parts, that arise within the autopod, at the distal end of the 
muscle, modularly forming a differentiated linear tendon [60]. Following the integration 
of zeugopod and autopod tendons at the wrist, muscle contractions appear to be necessary 
for further individuation of the autopod tendons. 
 Tendon Integration and Secondary Skeletal Structures 
 The most important outputs resulting from tendon-bone interactions are the 
formation of the secondary structures of the skeleton, eminences, and the sites of tendon-
bone insertion, entheses. The enthesis, or tendon-bone interface, is a specialized 
fibrocartilage matrix that serves as a graded transition zone between the collagen-rich 
matrix of the tendon and the highly mineralized bone matrix [70]. These attachment sites 
form by the end stages of embryonic development but undergo maturation postnatally 
[71-73]. This maturation process additionally requires muscle loading for proper 
development. If muscle paralysis is induced at early postnatal stages, growth, 
maintenance, and mineralization of the fibrocartilage matrix are all severely 
compromised [72]. Additionally, the maturation process appears to be dependent, at least 
in part, on hedgehog signaling [74, 75]. Lineage tracing of Hedgehog-responsive cells by 
Gli1-CreER, demonstrated that enthesis fibrocartilage cells are derived from this 
population [74]. Cell ablation or inhibition of the Hedgehog signaling response within 
this population leads to defects in fibrocartilage development; however, the source of 
Hedgehog ligand for enthesis development remains unclear [74, 75]. 
A subset of tendons will integrate with the skeleton at specialized protrusions 
from the long bone surface termed eminences [76]. These specialized secondary 
structures of the skeleton are derived from a unique pool of Sox9 and Scx double-positive 
progenitors that are distinct from the main skeletal elements and function to dissipate 
mechanical stress from muscle contractions [77, 78]. Double-positive eminence 
progenitors undergo differentiation and assume either a tendon or cartilage cell fate to 
generate the tendon-bone interface and integrate the two tissues. Interestingly, if cartilage 
fate is inhibited through Sox9 deletion in Scx-expressing cells, there is a complete loss of 
eminence formation. However, tendons still differentiate and attach to the skeleton [77]. 
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Alternatively, if Scx is inhibited there is also a loss of eminence formation due to a loss 
of BMP expression resulting in the inhibition of normal cartilage differentiation [77, 79]. 
Following the initial patterning of eminence progenitors, subsequent maintenance and 
growth requires muscle loading. Inhibition of muscle contraction or complete loss of 
muscle will result in loss of the secondary structure by the end of embryonic development 
[79]. Therefore, eminence formation represents a unique situation requiring proper 
integration of all three skeletal tissues for normal development.  
Establishment of Regional Patterning 
A critical component in patterning the musculoskeletal system is the incorporation 
of regional differences in patterning along the anterior to posterior axis of the vertebrae 
and the proximal to distal axis of the limb. The same tissue components, muscle, tendon, 
and bone, are present throughout the limb, but substantial morphological differences and 
unique connections occur within these tissues along the axial and limb skeletal axes. How 
these tissues form precise connections, sometimes spanning two regions of the limb, and 
integrate into a functional unit is largely unknown. Critical examination of the Hox11 
mutant phenotype provides new data suggesting that regional pattering information is 
informed, at least in part, by the master developmental regulators, the Hox genes [80].  
A Hoxa11eGFP knock-in mouse model was utilized to examine Hox11 
expression in detail within the developing limb [80, 81]. Characterization of 
Hoxa11eGFP expression in whole mount and in longitudinal limb sections shows broad 
expression throughout the distal limb bud mesenchyme early in development [80]. This 
expression is rapidly restricted to the presumptive zeugopod by E12.5 [Figure 1.3A]. 
Interestingly, Hoxa11eGFP-positive cells are excluded from the Sox9-expressing 
chondrogenic precursors and early Osterix (Osx) positive osteoblast progenitors at all 
stages of development [Figure 1.3B] [80]. Careful examination shows Hoxa11eGFP-
positive cells in the outer perichondrial layer surrounding the zeugopod condensations 
immediately adjacent to the chondrocyte and osteoblast cells. Hoxa13GFP expression has 
also been reported to be expressed in the perichondrium and excluded from condensing 
cartilaginous elements [82] .Co-expression analyses also revealed Hoxa11eGFP is not 
expressed within developing muscle cells [80]. Rather Hoxa11eGFP expression is  
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Figure 1.3: Hox11 is expressed in the connective tissue (stromal) compartment of the 
forelimb. (A) Hoxa11eGFP expression is restricted to the zeugopod and excluded from 
bone and muscle cells. Hox11 is expressed in the outer perichondrium surrounding the 
bones, in the muscle connective tissue, and in the tendons. (B) Longitudinal section of 
E14.5 forelimb showing expression of Hox11eGFP (green) surrounding the Sox9+ (red) 
skeletal elements. (C) Transverse view of an individual forelimb muscle bundle at E14.5 
showing expression of Hox11eGFP (green) in the muscle connective tissue surrounding 
individual muscle (red) cells. My32, myosin 32.  
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observed within all muscle connective tissue cells and in the connecting tendons [Figure 
1.3C] [80]. The collective data demonstrating the importance of the connective tissue 
elements of the limb in integrating the musculoskeletal unit suggested additional 
patterning roles for Hox beyond the skeleton. 
As mentioned previously, the cartilage elements destined to become the zeugopod 
bones condense normally in Hox loss-of-function mutants, but the pattern is not 
elaborated to form morphologically appropriate bones [16, 21-23, 83]. In addition to the 
well-described regional skeletal phenotypes, severe mis-patterning of the zeugopod 
muscles and tendons is observed in Hox11 loss-of-function mutants [80]. Early tendon 
progenitors are specified in Hox11 mutants and appear similar to controls, suggesting that 
Hox functions in patterning and integration but does not function in specification of the 
connective tissue elements. Additionally, the migration of muscle precursors into the 
limb occurs normally and dorsal and ventral muscle masses are present. However, the 
subsequent splitting of the masses into individual muscle bundles is abnormal and loss or 
fusion of various muscle groups is observed [80]. Loss of Hox11 function does not 
appear to affect muscle differentiation.  
Development and patterning of the skeletal elements remains normal in Hox11 
compound mutants where one of the four functional Hox11 alleles of the forelimb (either 
Hoxa11 or Hoxd11) is still expressed [16, 21, 80, 83]. The question of whether the 
muscle and tendon defects represent an independent role for Hox11 in patterning these 
tissues, or whether the phenotypes are simply a consequence of the severely disrupted 
skeletal patterning can, thus, be addressed. In Hox11 compound mutants, skeletal 
patterning is preserved but regional mis-patterning of the muscles and tendons is still 
observed, demonstrating that the muscle and tendon phenotype is independent of skeletal 
pattern [80]. Therefore, Hox11 genes function in patterning and integration all of the 
tissues of the musculoskeletal unit beyond just skeleton development. These analyses also 
demonstrate that skeletal patterning and muscle/tendon patterning can be uncoupled. 
Analysis of limb muscle and tendon phenotypes in other posterior Hox gene paralogous 
mutants has not been performed in detail, but given the conserved skeletal defects 
comparing loss-of-function of the 5’ Hox paralogs, I hypothesize that similar muscle and 
tendon phenotypes will be observed. 
13		
The observation that Hox11 is not expressed in differentiated cartilage, bone, or 
muscle tissues but in the connective tissues of the limb including the perichondrium, 
tendon, and muscle connective tissue, significantly alters predictions for the mechanism 
of Hox11 function in patterning the limb. Consistent with the body of work establishing 
essential roles for connective tissue elements in musculoskeletal patterning and 
integration, these data support a model whereby all Hox-mediated regional patterning 
information is contained within the stromal populations of the limb. Tcf4-Cre lineage-
tracing experiments revealed that muscle connective tissue, tendon, and eminence cells 
were all derived from the Tcf4-lineage and suggested the possibility that all the 
connective tissues of the limb are derived from a single progenitor population that 
integrates the musculoskeletal system [66, 84]. The continuum of Hoxa11eGFP-
expression throughout the connective tissue elements is consistent with Hox-expression 
defining this putative progenitor population in the zeugopod region.  
Hox Function Beyond Embryogenesis 
 Complete loss of an entire paralogous Hox group are generally embryonically 
lethal and are not observed in human patients, however mutations in specific Hox genes 
have been associated with several congenital disorders. For example, hand-foot-genital 
syndrome, a rare autosomal dominant disorder, is likely caused by a predicted loss-of-
function mutation of Hoxa13 due to a polyalanine tract expansion [85, 86]. Additionally, 
patients with cognitive dysfunction associated with Bosley-Salih-Alorainy syndrome and 
Athabascan brainstem dysgenesis syndrome are linked to mutations in Hoxa1 [87]. 
Beyond development, there is growing evidence for continuing functions for Hox genes 
in multiple organ systems in adult tissue homeostasis and in cancer. Hox genes continue 
to be expressed at adult stages in many tissues and the regional domains established 
during development appear to be maintained [88, 89]. In the lung, loss of the Hox5 
paralogs results in severely hypoplastic lungs and ongoing work has implicated 
continuing functions for the Hox5 genes in alveolar development in the lung, a process 
that occurs exclusively after birth in mice [[90, 91], Hrycaj et al. in preparation]. In the 
hematopoietic system, multiple Hox genes are expressed in hematopoietic stem cells 
(HSCs) and other immature myeloid sub-population and have been implicated in 
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regulating proliferation and differentiation [92-97]. Despite abundant genetic evidence 
for H0ox gene function in the hematopoietic system, their mechanism of action remains 
unclear. There is substantial evidence for deregulation of Hox gene expression in 
numerous adult solid tumor and blood cancers including; colorectal, breast, prostate, 
ovarian, bladder/kidney, thyroid, lung, acute myeloid leukemia (AML), and mixed-
lineage leukemia (MLL) [reviewed [98-100]]. General principles of Hox function in 
cancer have not been established and the mechanism of action is highly context 
dependent. Additionally, both oncogenic and tumor suppressive roles have been 
attributed to different Hox genes, sometimes even the same Hox gene, in specific 
contexts. In breast cancer, high levels of Hoxb13 is associated with increased tumor cell 
invasiveness; thereby acting as an oncogene [101]. These patient observations are 
recapitulated in vitro where forced expression of Hoxb13 in breast epithelial cells results 
in increased cell motility and invasiveness [102]. While in the prostate, forced expression 
of Hoxb13 in prostate cancer cell lines inhibits activation of the androgen receptor, 
slowing cell growth, and thereby preventing tumorigenesis [103, 104]. The role of Hox 
genes in cancer has, perhaps, been most significantly investigated for Hoxa9 in leukemias 
[100]. High levels of Hoxa9 expression are correlated with poor prognosis in acute 
leukemia, and clinically Hoxa9 is used as a biomarker [100]. Multiple upstream genetic 
alterations have been described resulting in upregulation of Hoxa9 including 
translocations and fusion events, sometimes even with the C-terminal Hox homeodomain, 
as well as deregulation of polycomb gene expression [100]. Ongoing study into the 
function of Hox in both the healthy and disease state will be important given clear 
functions for Hox in a diverse array of cancers and the therapeutic potential for targeting 
Hox genes or their downstream effectors. 
 As mentioned previously, Hox11 compound mutants display largely normal 
skeletal development during embryogenesis however these animals begin to display 
morphological defects during the postnatal growth period [21, 105]. Expression analysis 
of fracture calluses indicated increased levels of several homeodomain containing 
proteins including Msx1, Msx2, Prx1, Hoxa2 and Hoxd9 [106]. A different group 
performed microarray analyses on femur fracture callus samples throughout the healing 
process and observed increased Hox gene expression throughout the whole time course of 
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repair [107]. These observations strongly suggest continuing functions for Hox genes in 
the skeleton. 
 Our group recently used an ulnar fracture model to elucidate the function of 
Hox11 during skeletal repair [108]. These studies utilized Hox11 compound loss-of-
function mutants (Hoxa11+/-;Hoxd11-/- or Hoxa11-/-;Hoxd11+/-) to assess Hox 
function during the course of injury repair. Hox11 compound mutants display defects at 
multiple stages of injury repair suggesting functions for Hox throughout the processes. 
During early stages of fracture repair, Hox11 compound mutants exhibit reduced 
endochondral ossification and generate significantly less cartilage volume within the 
callus, resulting in incomplete bridging of the fracture gap [108]. At later stages, Hox11 
compound mutants display incomplete bone remodeling with the bone never recovering 
back to its original structure and form [108]. There is a clear similarity between the 
apparent chondrogenesis defects observed in fracture repair and the early arrest of 
chondrocyte differentiation within the skeletal anlagen during development of Hox11 
mutants suggesting potentially conserved functions for Hox throughout life. 
 To provide insight into the mechanism of Hox function at adult stages, significant 
effort was devoted to establishing the identity of adult Hoxa11eGFP-expressing cells at 
homeostasis and during injury repair. Characterization of Hox11eGFP expression 
throughout postnatal and adult stages demonstrated that Hox11-expressing cells remain 
regionally restricted to the zeugopod throughout life [109, 110]. During fracture healing, 
Hox11-expressing cells expand immediately throughout the fracture callus and stay 
localized to the bone surfaces throughout the repair process [108]. Extensive co-
expression studies determined that, similar to embryonic development, Hoxa11eGFP was 
not expressed in any differentiated cell type within the skeleton including chondrocytes, 
osteoblasts, osteocytes, blood vessels, hematopoietic cells, or neurons [80, 110]. Flow 
cytometry analyses determined that Hoxa11eGFP-positive cells were restricted to the 
non-hematopoietic, non-endothelial stromal compartment within the bone marrow space 
and in the perichondrium [110]. Through the use of cell surface markers and genetic 
lineage-tracing models, Hox11-expressing cells were identified as exclusively labeled by 
the bone marrow mesenchymal stem/stromal cell (MSC) surface markers PDGFRα/CD51 
and Leptin Receptor (LepR) and by LepR-Cre [110]. 
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 Skeletal Mesenchymal Stem Cells 
The existence of multi-potent mesenchymal stromal cells (MSCs) in the skeleton 
was first demonstrated by Friedenstein and colleagues when they established that plastic 
adherent cells isolated from bone marrow could form fibroblastic colonies (CFU-F) in 
cell culture, differentiate into bone, and reconstitute the hematopoietic microenvironment 
when transplanted in vivo [111-115]. Two main functions have been attributed to skeletal 
MSCs. The first function is to serve as a reservoir of new cellular material to maintain 
skeletal integrity throughout the life of the animal [116, 117]. The second function is as a 
component of the HSC niche [118-121]. The niche refers to the physical environment 
where HSCs reside within the bone marrow space and functions to preserve the stem cell 
state both through direct cell-cell contact and through paracrine production of specific 
signaling factors [122]. Bone marrow stromal cells express several important HSC niche 
factors including C-X-C motif chemokine 12 (CXCL12), stem cell factor (Scf), and 
angiopoietin 1 (Ang1) that are necessary for HSC maintenance [123]. Elimination of 
MSC populations or deletion of HSC niche factor expression in MSCs through genetic or 
pharmaceutical methods leads to reductions of long-term HSCs [120, 121, 124-127]. 
Today, several overlapping mesenchymal stromal populations of cells have been defined 
that enrich, to varying degrees, for cells with stem cell capacity [reviewed in extensive 
detail [119, 128, 129]. However, unlike the hematopoietic system where the HSC has 
been unequivocally defined, an analogous cell has not been precisely described in the 
mesenchymal compartment. It is important to highlight here that the existence of a self-
renewing mesenchymal stem cell capable of giving rise to bone, cartilage, and fat has, 
thus far, only been demonstrated clonally through in vitro differentiation assays or via 
transplantation of a cultured clonal population. Single-cell clonal tracing to demonstrate 
both multi-lineage contribution and self-renewal has yet to be performed in vivo. 
 The earliest genetically marked population to be rigorously tested to enrich for 
progenitor-enriched MSCs was defined by GFP expression driven by the Nestin 
promoter. Nestin-GFP-positive cells were shown to be rare, perivascularly-localized 
stromal cells within the bone marrow space [121]. The Nestin-GFP positive population 
was shown to contain all the CFU-F capacity in the bone marrow and these cells undergo 
multi-lineage differentiation into the skeletal mesenchymal lineages; osteoblasts, 
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chondrocytes, and adipocytes [121]. Self-renewal was demonstrated clonally through 
serial transplantation supporting that this population enriches for cells with multi-potent 
stem cell activity [120, 121]. When the lineage capacity of the Nestin-GFP positive 
population was tested in vivo using an inducible lineage-tracing model, Nestin-CreER, 
the Nestin-lineage marked cells were shown to contribute to bone and cartilage lineages 
in vivo [Figure 1.4 and [121, 130]]. Interestingly, contribution to adipocytes was not 
reported following adult-lineage induction, and no contribution was observed from 
postnatal Nestin-lineage marked cells [130]. This apparent contradiction in multi-lineage 
capacity of Nestin-GFP expressing stromal cells and Nestin-lineage marked cells has not 
been resolved, but conflicting results suggests assays in which cells have been placed in 
vitro and subsequently transplanted may not represent in vivo functions. It is important to 
note that Nestin-GFP is also expressed in endothelial cells within bone marrow, and 
Nestin-CreER lineage tracing reveals substantial contributions to the endothelial lineage 
particularly from fetal and early postnatal stages [130]. Curiously, several Nestin 
transgenes have been generated and they do not identify completely overlapping 
populations. Cells expressing the Nestin-GFP transgene discussed above express little 
endogenous Nestin, Nestin-CreER, or Nestin-mCherry, obfuscating the identity of the 
marked population [125, 130]. Nestin-CreER was additionally shown to preferentially 
label Nestin-GFP expressing endothelial cells during developmental stages [130]. These 
differences in expression could explain some of the discrepancies between the clonal in 
vivo/in vitro analyses and the genetic models. 
 Bone marrow stromal cells expressing the combination of cell surface markers 
PDGFRα/CD51 or Leptin Receptor (LepR) identify a largely overlapping population 
within the cells marked by Nestin-GFP [131, 132]. As expected, the stromal cell 
population identified by these markers also encompasses the majority of CFU-F in the 
bone marrow, undergoes tri-lineage differentiation into bone, cartilage and fat in vitro, 
and is capable of self-renewal by CFU-F culture analyses and serial clonal transplantation 
[131, 132]. It is important to note that only ~10% of LepR cells form CFU-F and only 
~10% of clonal colonies undergo tri-lineage differentiation with the remaining clones 
showing a bias towards osteogenic-forming colonies, highlighting the heterogeneity 
within this population [132]. While CFU-F capacity is not a direct measure of stem cell 
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number, and clonal in vitro differentiation experiments are technically challenging, these 
data suggest that the true mesenchymal stem cell is only a fraction of the total population 
and remains to be more specifically defined. 
 Additional sub-populations have been identified that enrich for progenitor-
enriched MSCs with varying characteristics. Cells co-expressing PDGFRα and Sca1 
represent a very small fraction of the PDGFRα/CD51 population that is highly enriched 
for CFU-F, however does not contain all CFU-F in the bone marrow [132, 133]. 
PDGFRα/Sca1 cells are clonally capable of tri-lineage differentiation in vitro [133]. 
Stromal cells expressing CXCL12, otherwise known as CAR cells, are bi-potent osteo-
adipo progenitors in vitro [134]. CAR cells appear to be mutually exclusive from 
PDGFRα/Sca1 cells as there is no expression of CXCL12 within the PDGFRα/Sca1 
population [133]. Through extensive fractionation of the bone marrow stroma using 
markers CD51 (AlphaV integrin), CD105, Thy, 6C3 and CD200, cells co-expressing 
CD51 and CD200 were demonstrated to sit at the top of a stromal hierarchy giving rise to 
all seven of the other identified sub-populations in vitro and in vivo [135]. For these 
experiments, each sub-population of stromal cells was either clonally cultured in vitro or 
transplanted into the renal capsule in vivo and the lineage hierarchy was determined by 
flow cytometry analysis of the expanded population following a period of colony 
expansion [135]. CD51/CD200 cells, termed mouse skeletal stem cells (mSSCs) are 
multi-potent in vivo and in vitro and self-renewal was demonstrated through serial 
transplantation [135]. During development, PDGFRα/Sca1 cells and CD200-positive 
mSSCs arise as two mutually exclusive sub-populations from within the PDGFRα/CD51 
population [136]. Most recently, Hoxa11eGFP-expressing cells were found to be 
exclusively identified as a sub-population of PDGFRα/CD51- and LepR-positive bone 
marrow stromal cells [110]. The Hoxa11eGFP-positive sub-population was shown to 
further enrich for CFU-F potential as compared to the total PDGFRα/CD51 population, 
suggestive of even further enrichment for progenitor-enriched MSCs, and Hox-positive 
cells undergo tri-lineage differentiation in vitro [110]. As mentioned above, Hox 
expression is regionally restricted within the skeleton during development. Using LepR-
Cre lineage-marked stromal cells isolated from different regions of the skeleton, Rux and 
colleagues demonstrated that Hox expression is exclusive to the LepR-lineage marked 
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stromal fraction, and that LepR-lineage marked cells isolated from different regions of the 
body express a Hox profile consistent with the expression domains established during 
embryonic development [110].  
 Ubiquitous and inducible lineage-tracing alleles have been used to interrogate the 
multi-lineage potential of progenitor-enriched MSC populations in vivo. Adult bone 
marrow stromal cells marked by Cre driven by the LepR promoter (LepR-Cre) faithfully 
mark the PDGFRα/CD51 and LepR-positive progenitor-enriched MSC population, and 
are the major source of bone and fat in the adult mouse [Figure 1.4 and [132]]. LepR-
lineage marked cells did not give rise to chondrocytes during homeostasis but were 
capable of giving rise to cartilage within the callus following fracture injury [132, 137]. 
Interestingly, LepR-lineage marked cells begin to appear around E17.5 but do not make 
any substantial contribution to osteoblasts and osteocytes until at least 2 months of age, 
suggesting this lineage gives rise to adult MSCs but does not support embryonic 
development and postnatal growth [132, 137]. It is important to note that LepR-Cre is not 
a temporally controlled model and, therefore, new cells will continuously be marked by 
this allele as LepR, and thus LepR-Cre, is expressed. This precludes the unequivocal 
identification of a single MSC population. While this allele has been helpful in assessing 
the dynamics of adult progenitor-enriched MSC populations, the critical caveats of this 
model must be remembered and care taken to appropriately assess these data. 
 The timing of lineage-contribution to differentiated cells in the LepR-Cre model 
revealed that embryonic bone development and postnatal growth is not supported by the 
cells marked by LepR-Cre. Numerous genetic models have been explored to identify 
earlier skeletal progenitors. Prx1-Cre labels the entire early limb bud mesenchyme, 
derived from the lateral plate mesoderm, and gives rise to CAR cells, periosteal cells, and 
LepR-positive stromal cells demonstrating that adult MSCs arise from cells within the 
early limb bud [Figure 1.4 [134, 138]]. It was unclear from these data whether a more 
precise stem cell origin could be identified.  
Multiple groups have investigated this question and proposed some unique 
insights into the nature of developmental progenitors of the skeleton. The most rigorously 
investigated inducible model is Osterix-CreER [137, 139, 140]. Osterix (Osx) is a critical 
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early transcription factor required for osteoblast differentiation. Osx-lineage marked cells 
behave differently depending on the timing of lineage induction [Figure 1.4]. Cells 
marked by Osx-CreER at embryonic stages contribute substantially to bone formation 
during development and postnatal growth, but contribution ceases by adult stages and this 
population is depleted with time [139, 140]. Embryonic cells marked by Gli1-CreER at 
similar stages exhibit multi-lineage contribution to the skeleton at adult stages (8 weeks), 
but the long-term persistence of this population was not reported [Figure 1.4 and [141]]. 
The same Gli1-CreER marked population at later stages functions as an osteo-lineage 
restricted progenitor with no stromal cell contribution [141]. In contrast, early postnatal 
Osx-lineage marked cells contribute to bone during growth and adult homeostasis and 
persist as bone marrow stromal cells out beyond 1 year of age [137, 140]. Interestingly, 
the contribution of postnatal Osx-lineage marked cells to bone decreases as the animal 
ages despite the persistence of a marked stromal population suggesting heterogeneity 
within the initially marked population [140]. Long-lived Osx-lineage marked stromal 
cells are Nestin-GFP-, LepR-, and PDGFRα-positive [137, 140]. There is more 
significant Osx-lineage contribution to CAR cells over PDGFRα/Sca1 cells in the bone 
marrow following chasing to adult stages [140]. Lineage-tracing of 
perichondrial/periosteal cells by Col2-CreER or chondrocyte lineage cells by Sox9-
CreER or Aggrecan-CreER demonstrated similar capacity to give rise to long-lived bone 
marrow stromal cell populations from postnatal stages, but not other stages [Figure 1.4 
and [140]]. Postnatal and adult cells labeled by Gremlin 1-CreER (Grem1-CreER) also 
exhibit long-term persistence, but function as lineage-restricted osteo-chondro 
progenitors [Figure 1.4 and [142]]. The embryonic Grem1-lineage was not examined 
beyond birth. Finally, adult Osx-CreER lineage-marked cells are osteo-lineage restricted 
and only contribute to bone for a short period of time before they are depleted [140]. 
From these collective data, a model for skeletal progenitors was proposed whereby 
embryonic development is supported by early skeletal progenitors which are replaced by 
definitive skeletal progenitor-enriched MSCs that arise during postnatal stages [118, 
128]. 
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Figure 1.4: Comparison of genetic MSC lineage populations. MSC populations 
genetically marked by various Cre/CreER models display different lineage dynamics over 
time. The appearance of each population or the time point of tamoxifen induction (black 
circle) and the analysis end point (arrow) for each model is noted. Lineage contribution 
not reported beyond a certain stage is indicated by vertical bar. Brief summary of the 
skeletal contribution and MSC-like behavior is indicated.  
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 One important critique of the ‘two-waves-of-progenitors’ model comes from the 
nature of the genetic models utilized to generate this hypothesis. The majority of the 
mouse models analyzed employ an inducible CreER driven by promoter of genes known 
to be involved in early chondrogenic (Sox9 and Aggrecan) or osteogenic (Osterix) 
differentiation. Additionally, as has been shown for many stem cell populations, skeletal 
stem cells are thought to be primed to differentiate into multiple lineages and therefore 
have initiated expression of multiple early commitment factors despite not committing to 
a given lineage [143]. One interpretation of these results is that most of the cells marked 
by these inducible CreER alleles will be committed cartilage or bone progenitors, 
respectively, while the true progenitors will be inefficiently and stochastically labeled. 
Therefore, the interesting dynamics of the Osx-CreER lineage-marked population, for 
instance, may be more representative of the behavior of early osteo-progenitors and less 
indicative of the true skeletal stem cell.   
Summary of thesis work 
 The work presented in this thesis aims to understand the mechanism of Hox11 
function in the skeletal system, to define the nature of Hox11-expressing cells in the 
skeleton at all stages, and to assess the stem/progenitor potential of Hox11-expressing 
cells throughout life. Hox11 compound mutant skeletons are indistinguishable from 
controls at birth, but by adult stages the bones display an abnormal morphology 
characterized by shorter elements and an anterior bowing of the radius [21, 80, 83]. I first 
characterized the postnatal growth defects displayed by Hox11 compound mutants as the 
development of this phenotype has not been assessed in great detail prior to this work. I 
characterized the progression of the Hox11 compound mutant bone phenotype from birth 
to 8 weeks of age and demonstrated a reduced growth rate in both bones. Interestingly, 
the ulna growth rate was disproportionately reduced potentially contributing to the 
abnormal bowed morphology of the radius. Defects in the rate of chondrocyte 
proliferation within the reserve and proliferative zones were observed resulting in 
depletion of the immature chondrocyte pool and premature growth plate collapse. The 
proliferative defects additionally uncouple the growth rate between the radius and ulna 
thereby contributing to the abnormal skeletal morphology by adult stages. These data 
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provide evidence for continuing functions for Hox11 genes in the skeleton outside of 
development and support an important role for Hox11 in regulating chondrocyte 
proliferating and differentiation within the growth plate. 
Previous work from the Wellik lab identified adult Hoxa11eGFP-expressing 
stromal cells to be identified by markers for bone marrow MSCs [110]. However, these 
data did not establish whether Hox11-expressing cells function as MSCs in vivo. 
Additionally, given the continuum of Hox11eGFP-expression throughout life and genetic 
evidence supporting Hox11 function in the skeleton throughout life, I hypothesized 
Hox11-expressing cells represent a continuous skeletal progenitor population. To test the 
stem/progenitor potential of the Hox11-expressing population in vivo, I generated 
Hoxa11 lineage-tracing allele using Cas9/CRISPR. The first allele contains a tamoxifen 
inducible CreERT2 knock-in to the endogenous Hoxa11 locus, Hoxa11-CreERT2.  I show 
that Hoxa11-lineage marked cells give rise to all the skeletal mesenchymal lineages 
(cartilage, bone, and adipose) and provide evidence that Hox11-expressing MSCs self-
renew for the life of the animal. These data reconcile conflicting data in the field and 
demonstrate for the first time that long-lived skeletal stem cells population arise during 
embryonic development and persist throughout life. 
There is evidence supporting continuing functions for Hox11 genes in the 
skeleton during embryonic development, postnatal growth, and adult fracture repair [80, 
109, 110]. However, paralogous Hox11 loss-of-function mutants are embryonic lethal 
precluding study of complete mutants at postnatal and adult stages. I additionally 
generated a Hoxd11-conditional allele which, when combined with Hoxa11 loss-of-
function, will allow for generation of complete Hox11 loss-of-function mutants in a 
stage-specific and/or cell type-specific manner through the use of various Cre/CreER 
models. I show preliminary data confirming the functionality of this new allele and this 
work will be continued by other members of the Wellik lab. 
Finally, I present data exploring potential mechanisms for Hox11 function during 
the early stages of skeletal development. Hox11 mutants display chondrogenic 
differentiation defects that first manifest around E12.5, however the mechanism of 
Hox11 function regulating the early stages of skeletal patterning and development are 
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unknown [83]. Careful comparative expression analyses of three genes with critical 
functions in early skeletal development, Indian Hedgehog (Ihh), Runx2, and Wnt5a, were 
performed in Hox11 control and mutant embryo forelimbs. Hox11-expressing cells in the 
perichondrium appear to respond to IHH ligand through up-regulation of Gli1-lacZ 
signal. These data are consistent with the hypothesis that Hox11 cooperates with the 
Hedgehog signaling pathway in the perichondrium to pattern the developing skeletal 
elements. These studies provide a foundation for future experiments to determine the 
nature of the Hox and Hedgehog pathway interactions.   
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CHAPTER II 
Hox11 genes regulate postnatal longitudinal bone growth and 
growth plate proliferation. 
Summary 
 Hox genes are critical regulators of skeletal development and Hox9-13 paralogs, 
specifically, are necessary for appendicular development along the proximal to distal 
axis. Loss of function of both Hoxa11 and Hoxd11 results in severe malformation of the 
forelimb zeugopod. In the radius and ulna of these mutants, chondrocyte development is 
perturbed, growth plates are not established, and skeletal growth and maturation fails. In 
compound mutants in which one of the four Hox11 alleles remains wild-type, 
establishment of a growth plate is preserved and embryos develop normally through 
newborn stages, however, skeletal phenotypes become evident postnatally. During 
postnatal development, the radial and ulnar growth rate slows compared to wild-type 
controls and terminal bone length is reduced. Growth plate height is decreased in mutants 
and premature growth plate senescence occurs along with abnormally high levels of 
chondrocyte proliferation in the reserve and proliferative zones. Compound mutants 
additionally develop an abnormal curvature of the radius, which causes significant 
distortion of the carpal elements. The progressive bowing of the radius appears to result 
from physical constraint caused by the disproportionately slower growth of the ulna than 
the radius. Collectively, these data are consistent with premature depletion of forelimb 
zeugopod progenitor cells in the growth plate of Hox11 compound mutants, and 
demonstrate a continued function for Hox genes in postnatal bone growth and patterning.  
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Introduction 
 The proximodistal elongation of long bones occurs through the process of 
endochondral ossification within the growth plate. The growth plate is organized into 
distinct cellular zones: the reserve or resting zone (RZ), the proliferative zone (PZ), and 
the prehypertrophic/hypertrophic zone (HZ).  Chondrocytes at the epiphyseal end of the 
growth plate make up the RZ.  RZ chondrocytes are slow dividing, stem/progenitor cells 
which give rise to flattened columns of PZ chondrocytes [144]. Chondrocytes in the PZ 
proliferate rapidly and undergo morphological changes to become oriented into columns 
of cells arranged parallel to the long axis of the bone [145]. As cells in the columns reach 
the metaphyseal side of the growth plate and enter the HZ, it has been reported that 
chondrocytes exit the cell cycle, undergo hypertrophy and initiate apoptosis [146]. 
Concomitantly, hypertrophic chondrocytes secrete significant amounts of extracellular 
matrix which becomes mineralized and provides a template for new bone formation 
[147]. The cartilage matrix of the growth plate is subsequently remodeled and replaced 
by bone through the function of osteoclasts and osteoblasts. 
Longitudinal bone growth is regulated both locally and systemically by a host of 
hormones and growth factors that coordinate proliferation, matrix synthesis and 
differentiation of chondrocytes [148, 149]. While the differentiation program of growth 
plate chondrocytes is similar in all long bones, elongation occurs at different rates to 
allow each element to achieve correct proportionate lengths for the adult animal [150]. 
These rates of growth can vary dramatically. Indeed, growth plates at opposite ends of the 
same long bone can differ by a factor of two- to three-fold [150]. These differences in 
growth rate contribute to final bone lengths and morphology, however the processes that 
govern these differential rates of growth are poorly understood. 
Hox genes are a family of highly conserved, homeodomain-containing 
transcription factors crucial for axial and appendicular patterning. In the limb skeleton, 
Hox9-13 genes pattern the proximodistal axis and loss-of-function mutations of 
paralogous genes result in dramatic, region-specific perturbations of skeletal 
development. Loss of Hox9 and/or Hox10 genes results in mispatterning primarily of the 
stylopod element (humerus or femur) [16, 22]. Loss of Hox11 function leads to severely 
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truncated zeugopod skeletal elements (radius/ulna or tibia/fibula) [16, 21, 83]. In 
Hoxa13/Hoxd13 mutants, the autopod skeletal elements (hand or foot bones) are affected 
[23, 151, 152]. The genetic requirement for Hox genes during development is well 
documented, but continuing roles for these genes postnatally is less explored. 
A high degree of functional redundancy exists between members of a Hox 
paralogous group. For example, single allele mutants of Hoxa11 or Hoxd11 exhibit minor 
developmental defects, which include fusion of various carpal bones, minor 
malformations of the distal epiphyseal end and a slight thickening of the radius and ulna 
[153-155]. These phenotypes are in stark contrast to the dramatic mispatterning observed 
when all Hox11 paralogous genes are lost (Hoxa11-/-;Hoxd11-/- in the forelimb or 
Hoxa11-/-;Hoxc11-/-;Hoxd11-/- in the hindlimb). In these mutants, the cartilage anlage 
condense normally, however, the subsequent maturation of the chondrocytes fails, an 
organized growth plate is not established and no skeletal pattern is elaborated [83]. 
Interestingly, maintenance of a single functional allele of Hoxa11 or Hoxd11 is sufficient 
to allow for normal embryonic skeletal development in the forelimb [21, 80, 83]. In these 
Hox11 compound mutant embryos, no differences in proliferation, apoptosis, or overall 
skeletal growth was observed [83]. However, by adult stages, Hox11 compound mutant 
animals exhibit a significant reduction in zeugopod skeletal length [21]. The purpose of 
this study was to define the morphological and cellular processes that contribute to the 
postnatal growth defects in Hox11 compound mutants during postnatal development. 
We show that Hoxa11 and Hoxd11 continue to be expressed in the forelimb 
zeugopod throughout postnatal stages. Consistent with previous reports, the skeletal 
morphology of Hox11 compound mutants is indistinguishable from controls at birth. 
However, during postnatal growth, the compound mutant radius and ulna grow at slower 
rates than controls at all time points examined and growth arrests at earlier stages. 
Despite total bone lengths being comparable to controls at birth, growth plate length is 
shortened in compound mutants. Chondrocytes are prematurely depleted in the mutant 
growth plate during postnatal growth correlated with increased levels of proliferation in 
the RZ and PZ. Additionally, the longitudinal growth of the compound mutant ulna is 
more severely affected than the radius resulting in a bone that is disproportionately 
shorter. The altered proportions of the radius and ulna contribute to an anterior bowing of 
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the compound mutant radius in adult animals. Together, these results demonstrate a 
continuing role for Hox11 genes in postnatal bone growth. 
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RESULTS 
Hox11 genes remain expressed through postnatal and adult stages 
 We previously published detailed developmental expression analysis of Hoxa11 
in the embryo utilizing a Hoxa11eGFP knock-in allele [80, 81]. Embryonically, 
Hoxa11eGFP is expressed in the connective tissue elements of the forelimb including the 
perichondrium/periosteum, tendon and muscle connective tissue with the strongest 
expression surrounding the distal end of the radius and ulna [80]. Utilizing this 
Hoxa11eGFP allele, we show that Hoxa11eGFP continues to be expressed at birth and 
through postnatal stages. Hoxa11eGFP is expressed strongly in the perichondrium and 
along the trabecular bone surface, with lower expression observed within the most distal 
RZ chondrocytes [Figure 2.1A-D]. Expression of Hoxd11 is observed in the connective 
tissue surrounding the distal radius and ulna in a pattern similar to Hoxa11eGFP 
expression [Figure 2.1E-F and data not shown]. qPCR analysis for both Hoxa11 and 
Hoxd11 on whole bones (radius and ulna) at E12.5, E18.5 and 1, 2, and 4 weeks of age 
demonstrates continued expression of both genes through adult stages.  Interestingly, 
Hoxd11 shows higher relative expression at embryonic stages, but both Hoxa11 and 
Hoxd11 remain expressed through adult stages. 
Abnormal postnatal skeletal growth in Hox11 compound mutants 
 To assess the development of the compound mutant skeletal phenotype during 
postnatal stages, we performed micro-computed tomography (µCT) analysis at 0, 2, 4, 6 
and 8 weeks of age on Hox11Aadd animals. The humerus was measured as an internal 
control for animal size as the length, bone quality, and bone morphology and was 
indistinguishable between Hox11 compound mutants and controls [Figure 2.2]. Skeletal 
preparations and isosurface renderings of µCT scans allow visualization of the 
morphology of the radius and ulna of control and Hox11 compound mutants throughout 
postnatal growth [Figure 2.3A]. While no statistical difference in mineralized bone length 
is measurable at birth, the length of the ulna is trending towards being shorter in mutants 
compared to controls and slight morphological differences in the radius and ulna can 
already be observed [Figure 2.3A-C]. Abnormal curvature of the radius in compound 
mutants is readily apparent at two weeks of age and becomes 
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Figure 2.1: Expression of Hoxa11 and Hoxd11 in postnatal development. (A-D) 
Expression of Hoxa11eGFP in E18.5 radius (A) and ulna (B) and in 2-week old radius 
(C) and ulna (D). In situ hybridization of Hoxd11 in E16.5 radius (E) and ulna (F). 
Dashed white line outlines the distal growth plate and brackets demarcate the zones of the 
growth plate. (G) qPCR analysis of Hoxa11 expression at E12.5, 18.5 and 1, 2, and 4 
weeks of age. (H) qPCR analysis of Hoxd11 expression at E12.5, E18.5 and at 1, 2, and 4 
weeks of age. (G-H) Expression values are relative to Hoxa11 or Hoxd11 expression in 
adult lung, which is set to ‘1’. All data presented as mean ± standard deviation. RZ: 
reserve zone, PZ: proliferative zone, HZ: hypertrophic zone. N=3-5, Scale bar = 200µm 
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Figure 2.2: Development of the humerus is unaffected in Hox11 compound mutants. 
(A) Mineralized length of the humerus in control (light grey) and Hox11 compound 
mutant (dark grey) at 0, 2, 4, 6, and 8 weeks of age was measured along the central 
curvature of the element. (B) µCT analysis of bone morphology and quality of the 
humerus of control (light grey) and Hox11 compound mutant (dark grey). Cortical area 
and thickness, inner and outer perimeter, and tissue mineral density was measured at 0, 2, 
4, 6, and 8 weeks of age. All data presented as mean ± standard deviation. N=5-10.  
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 progressively more severe through postnatal development. In addition, the distal 
radioulnar joint is dysmorphic and the radius of compound mutants progressively extends 
ectopically into the carpal bones [Figure 2.3A, arrows]. The overgrowth of the radius 
results in a forward subluxation of the hand and outwards rotation of the autopod. 
To begin to dissect the onset of the postnatal phenotypes, the mineralized lengths 
of the radius and ulna were measured along the central curvature of the bone at 0, 2, 4, 6, 
and 8 weeks of age [Figure 2.3A, solid and dashed lines]. No significant differences in 
mineralized length of the radius or ulna was observed at newborn stages between controls 
and compound mutants, consistent with previous reports [Figure 2.3B,C, [83]]. 
Differences in bone length are observed early in postnatal development and by 2 weeks 
of age, both the radius and ulna of the compound mutant are shorter compared to 
controls: the radius is 15% reduced and ulna 20% reduced. By 4 weeks of age, the 
differences in length between the compound mutant and controls are exacerbated further 
(radius 17%, ulna 27% reduced). Longitudinal bone growth has slowed dramatically or 
stopped in all bones in both controls and mutants by 8 weeks of age, and at this stage the 
Hox11 mutant radius is 22% shorter and the ulna is 30% shorter than their analogous 
control counterparts [Figure 2.3B,C].  
In both controls and mutants, the rate of bone growth decreases with age. 
Consistent with the reduction in total bone length, the growth rate of both the mutant 
radius and ulna is reduced compared to controls at all time points examined [Figure 2.3D, 
solid bars vs. open bars]. Interestingly, the rate of growth of the mutant ulna slows 
noticeably faster than the mutant radius, and growth of both elements has essentially 
stopped by 6 weeks of age in mutants [Figure 2.3D, solid blue bars vs. solid green bar]. 
While the compound mutant radius grows slower than controls throughout development, 
the decrease in growth rate over time is comparable to controls [Figure 2.3D, solid green 
bar vs. open green bar]. 
Bone mineral quality is not affected in Hox11 compound mutants 
 Bone quality of both Hox11 compound mutants and controls was analyzed by 
µCT analyses at 0, 2, 4, 6 and 8 weeks of age. No differences in any of the parameters 
measured, including cortical area and thickness, inner and outer perimeter, and tissue  
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Figure 2.3: Postnatal development of wild-type control and Hox11 compound 
mutant forelimb zeugopod. (A) Skeletal preparation of newborn (0 week) forelimb and 
3D rendering of µCT scans of 2, 4, 6 and 8 week forelimb from control and Hox11 
compound mutant. Dashed and solid lines indicate central curvature of the element. 
White arrows highlight distortion of the carpal bones by the radius in the compound 
mutant. (B-C) Mineralized length of the radius (B) and ulna (C) at 0, 2, 4, 6 and 8 weeks 
of age was measured along the central curvature of the element. (D) The rate of growth of 
the radius and ulna of controls and compound mutants was calculated between 0-2 week, 
2-4 week, and 4-6 week of age. All data presented as mean ± standard deviation. N=5-10. 
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mineral density were observed in the humerus of Hox11 mutants [Figure 2.2B]. In 
contrast, cross-sectional views of the radius and ulna through the mid-diaphysis of 
control and Hox11 mutants at 8 weeks of age highlight morphological differences in 
these animals. Note the bowing phenotype leads to a larger distance between the radius 
and ulna in compound mutants compared to controls [Figure 2.4A,B]. Compound mutant 
bones are show measured increases in cortical area, cortical thickness, and bone 
perimeter compared to controls [Figure 2.4C,D]. No differences in tissue mineral density 
are observed between control and Hox11 compound mutants demonstrating that, despite 
differences in bone thickness and size, bone quality appears to be comparable by this 
measure [Figure 2.4C,D].  
Appositional bone growth is not coordinated in Hox11 compound mutant radius 
and ulna. 
 To investigate bone growth and remodeling, we utilized dynamic 
histomorphometry to examine appositional growth patterns in the radius and ulna of 
control and compound mutants. New mineral deposition was analyzed by injection of dye 
at 2 weeks (xylenol orange label), 3 weeks (calcein label), and 4 weeks (alizarin 
complexone label) of age. Animals were assessed two days after the last injection.  
Growth patterns of control and compound mutants were analyzed at the mid-diaphysis 
where peak curvature is observed in mutant radii. Both xylenol orange (2 weeks) and 
alizarin complexone (4 weeks) are detected in the red channel, and new bone formed at 
these two time points can be distinguished by the presence of a green calcein label 
between the two labels. Rapid growth rates and high bone turnover make quantification 
of appositional growth rates unfeasible at these time points, however, qualitative 
differences in overall growth patterns between Hox11 compound mutants and controls 
can be assessed. Within the cortical bone of wild-type controls, there are relatively large 
distances between labels indicating significant amounts of growth between time points 
[Figure 2.5A-C]. Additionally, the distance between labels is not uniform, highlighting 
the dynamic nature of postnatal skeletal growth. The 3-week label (green) is present as a 
mostly uninterrupted layer throughout both zeugopod bones, the 4-week label (surface 
red layer) is observed uniformly on the endosteum of both bones in the control, while the 
2-week label (cortical red label) has been largely remodeled away by the time point of  
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Figure 2.4: µCT analysis 
of bone morphology and 
quality. (A-B) Cross-
sectional view of µCT 
scans at 8 weeks of age for 
control (A) and Hox11 
compound mutant (B) 
forelimb zeugopod. 
Cortical area and thickness, 
inner and outer perimeter, 
and tissue mineral density 
of the radius (C) and ulna 
(D) of control (light grey) 
and compound mutant 
(dark grey) animals were 
measured at 0, 2, 4, 6 and 8 
weeks of age. All data 
presented as mean ± 
standard deviation. N=5-10 
*p ‹ 0.05.  
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Figure 2.5: Appositional bone growth examined by dynamic histomorphometry. 
Wild-type control (A-C) and Hox11 compound mutant (D-F) animals were injected with 
xylenol orange (red), calcein (green), and alizarin complexone (red) at 2 weeks, 3 weeks 
and 4 weeks of age respectively. Representative bright field (A, D) and fluorescent (B, E) 
cross-sectional images of the mid-diaphysis were overlaid (C, F) to examine appositional 
growth patterns. Areas of appositional growth of the periosteal (blue arrows) and 
endosteal (white arrowheads) bone surface are highlighted. Scale bar = 100 µm. 
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analyses [Figure 2.5A-C]. Appositional growth in control animals is observed only on the 
posterior-distal periosteal surface of the radius and the anterior periosteal surface of the 
ulna corresponding to ridges that are being patterned on the bone surface [Figure 2.5A-C, 
blue arrows].  
In contrast to control animals, appositional growth in Hox11 compound mutants is 
consistently unidirectional in both the radius and ulna. Posterior growth is observed 
endosteally [Figure 2.5D-F, white arrowheads] and periosteally [Figure 2.5D-F, blue 
arrows] in both the radius and ulna. This strong unidirectional growth pattern is 
established by 2 weeks of age and continues through 4 weeks as demonstrated by 
incorporation and retention of all three labels [Figure 2.5D-F]. Minimal incorporation of 
label on the anterior surface of the compound mutant radius and ulna indicates a lack of 
new bone formation or high levels of remodeling on this surface. Taken together, the data 
demonstrate that Hox11 mutants enact active bone growth in opposition to the direction 
of anterior radial bowing, consistent with correctional growth. 
Hox11 compound mutant growth plates are morphologically abnormal and 
chondrocytes are prematurely depleted 
 Growth plate morphology was analyzed at 0, 2, 4, 6, and 8 weeks of age in 
controls and compound mutants to investigate whether premature depletion of 
chondrocytes contributes to the reduction in bone length in mutants. The growth plate 
length of the mutant radius and ulna is significantly shorter than controls at newborn 
stages despite the absence of significant differences in bone length at this stage, and the 
growth plate remains shorter throughout postnatal development [Figure 2.6A,B]. By 6 
weeks of age and beyond, differences in growth plate length are no longer statistically 
significant, likely due to physiological growth plate collapse in both controls and mutants 
by these stages [Figure 2.6A-B,O-V]. 
 All three zones of the growth plate: the reserve zone, proliferative zone, and 
hypertrophic zone, are established in the compound mutant, however, cellular 
organization of the growth plate is disorganized compared to controls. This is noted 
particularly in the PZ of the compound mutants. PZ chondrocytes are visualized 
histologically in clusters in the mutant animals, in contrast to the normal vertical columns 
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Figure 2.6: The distal growth plate of Hox11 compound mutant forelimb zeugopod 
bones undergoes premature senescence. (A-B) Total growth plate length of the radius 
(A) and ulna (B) from control (light grey) and compound mutant (dark grey) animals was 
measured from Safranin-O/Fast Green stained sections. Representative images of 
Safranin-O/Fast Green/Hematoxylin stained distal forelimb growth plates at 0 week (C-
F), 2 week (G-J’), 4 week (K-N), 6 week (O-R) and 8 week (S-V) old controls and 
compound mutants. Black brackets demarcate zones of the growth plate at 0, 2, and 4 
weeks (C-J). RZ: reserve zone, PZ: proliferative zone, HZ: hypertrophic zone. All data 
presented as mean ± standard deviation. N=4-5. *p ‹ 0.05, paired Student’s t-tests. Scale 
bar = 200 µm.  
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of flattened chondrocytes seen in controls [Figure 2.6D, PZ vs. Figure 2.6C, PZ and 
Figure 2.6F, PZ vs. Figure 2.6E, PZ]. While matrix secreted by the PZ chondrocytes is 
not uniformly organized vertically in Hox11 compound mutants, there are no apparent 
differences in the amount of matrix produced compared to controls [Figure 2.6D, PZ vs. 
Figure 2.6C, PZ and Figure 2.6F, PZ vs. Figure 2.6E, PZ]. Additionally, RZ chondrocytes 
are depleted more rapidly in mutants compared to controls; there are noticeably fewer 
cells in this zone by 2 weeks of age [Figure 2.6H’ vs. G’ and Figure 2.6J’ vs. I’]. 
 To examine the cause of the premature shortening of the growth plate in Hox11 
compound mutants, we examined proliferation rates in the RZ and PZ of the growth plate 
using BrdU labeling analysis. By histological analysis, the number of RZ chondrocytes is 
reduced by 2 weeks of age in mutants and therefore we focused our analysis to 0, 1, and 2 
weeks of age. Proliferation of growth plate chondrocytes in the mutant radius and ulna is 
higher in both the RZ and PZ than in controls, reaching statistical significance at 1 week 
in the ulna and 2 weeks in the radius [Figure 2.7A,B]. Representative images at E18.5, 1 
week and 2 weeks highlight the regional differences in proliferation in the growth plates 
of controls and Hox11 compound mutants [Figure 2.7C,D].  
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Figure 2.7: Proliferation defects are observed in the distal growth plate of Hox11 
compound mutant forelimb zeugopod bones. Proliferative index (PI) was calculated 
from total BrdU-positive nuclei relative to total nuclei in the reserve and proliferative 
zone at 0, 1 and 2 week in the radius (A) and ulna (B) of control (light grey) and 
compound mutant (dark grey) animals. Representative images of BrdU staining in the 
distal growth plate of the radius (C) and ulna (D) at E18.5, 1 week, and 2 weeks of 
control and Hox11 compound mutant. White brackets demarcate zones of the growth 
plate (C-D). RZ: reserve zone, PZ: proliferative zone, HZ: hypertrophic zone. All data 
presented as mean ± standard deviation. N=3-4. *p ‹ 0.05, paired Student’s t-tests. Scale 
bar = 200 µm.  
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Discussion 
 Herein, we show that Hox11 genes continue to be expressed and function during 
postnatal skeletal development. While preserving a single functional allele of Hoxa11 or 
Hoxd11 is sufficient for normal embryonic bone development, the radius and ulna of 
Hox11 compound mutant animals develop abnormal skeletal morphology postnatally 
compared to controls. The progressive anterior bowing of the mutant radius does not 
appear to be due to inferior bone quality or mis-directed appositional growth. In fact, both 
the compound mutant radius and ulna exhibit appositional growth consistent with 
compensatory growth. We demonstrate that the anterior radius bowing phenotype is 
likely to be the result of disproportionate longitudinal growth of the radius and ulna, with 
the ulna lagging in growth rate compare to the radius. Uncoordinated growth leads to 
bowing of the faster growing element, the radius. These data suggest that Hox11 genes 
function to coordinate the longitudinal growth of the distal growth plate of the radius and 
ulna. 
 Why the radius grows faster than the ulna in the Hox11 compound mutant is 
unclear. The genotype of the Hox11 compound mutant alone cannot explain the loss of 
coordinated growth of the radius and ulna since the radial bowing phenotype occurs to a 
similar extent in both compound mutant genotypes; Hox11Aadd or Hox11aaDd [21]. 
Embryonically, a single Hoxa11 or Hoxd11 allele is sufficient to support normal forelimb 
development. Therefore, both elements of the zeugopod clearly require Hox11 function 
for proper patterning during development. These observations highlight that Hoxa11 and 
Hoxd11 genes perform similar and highly overlapping functions during embryonic 
development and in regulating postnatal growth. Hoxa11 and Hoxd11 are strongly 
expressed in the mesenchymal tissue surrounding the distal ends of the radius and ulna 
embryonically and postnatally. One hypothesis to explain why the ulna is more severely 
affected than the radius during postnatal growth is that there is a differential requirement 
for Hox11 function in the ulna compared to the radius. However, the nature of this 
differential function has not been investigated in this work. Future studies utilizing 
conditional alleles of Hox11 for complete loss of Hox function in postnatal development 
will further clarify the function of Hox11 in regulating longitudinal skeletal growth.  
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 During longitudinal skeletal growth, there is tight regulation of proliferation and 
chondrocyte maturation within the growth plate. The majority of proliferation occurs 
within the columns of PZ chondrocytes, while RZ chondrocytes proliferate at a much 
reduced rate to contribute new cells to the PZ [144, 146, 156, 157]. Through postnatal 
development, there is a reduction in proliferation within the growth plate and a decrease 
in the height of the growth plate, a process termed growth plate senescence [158]. 
Senescence is a complex process; chondrocytes within the growth plate are only capable 
of a finite number of cell divisions and the balance of chondrocyte proliferation and 
timing of maturation determines bone length [158-161]. We show that there is a loss of 
proliferative regulation within the growth plate coupled with premature senescence in 
Hox11 compound mutants. Abnormally high levels of proliferation in both RZ and PZ 
chondrocytes are measured in the compound mutant ulna and radius, however 
longitudinal growth arrests earlier in these mutants. These observations provide evidence 
that the regulation of chondrocyte proliferation and maturation is no longer linked in 
Hox11 compound mutants. These data are consistent with a model whereby loss of 
Hox11 function results in premature depletion of RZ chondrocytes and, perhaps, 
accelerated differentiation resulting in overall shortened zeugopod bones.  
 We and others have demonstrated that Hox11 gene expression is restricted to the 
perichondrium and RZ chondrocytes and that Hox11 genes are not expressed within the 
PZ and HZ chondrocytes themselves [80, 83]. Since Hox genes encode for transcription 
factors, this raises the possibility that Hox functions to maintain an undifferentiated state 
within the RZ chondrocyte progenitor pool and regulates when RZ chondrocytes enter the 
PZ and begin to differentiate. Loss of Hox within RZ chondrocytes may result in a loss of 
progenitor identity, and thus, premature differentiation and depletion of the chondrocyte 
progenitor pool. This hypothesis is consistent with the phenotypes observed in embryonic 
Hox11 loss of function limbs. Hoxa11-/-;Hoxd11-/- mutant limbs are severely shortened, 
growth plates do not form, and chondrocyte maturation is perturbed [83]. Additionally, 
proliferation analysis in the Hox11 mutant radius and ulna show proliferation throughout 
the cartilage anlage in contrast to control limbs where proliferation is restricted to the 
distal growing ends. Similar to the postnatal limb, Hox11 genes are expressed at the distal 
end of the growing cartilage anlage embryonically; suggesting that Hox11 contributes to 
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maintaining progenitor identity and regulating the rate of proliferation and differentiation 
of chondrocytes in both the embryonic and adult context. 
Growth plate chondrocytes undergo a well-characterized differentiation program 
that is common to all long bones, however, the rate of growth between growth plates of 
different bones vary substantially [150, 162]. Neither systemic regulation nor local 
feedback loops can easily account for these differences since these factors are present in 
all growth plates. Our current data are consistent with a model whereby the differential 
growth rates across the skeleton are controlled, at least in part, by the HOX proteins 
expressed in each region. It is well documented that during development Hox9-13 
paralogs function in a highly region-specific fashion to pattern the appendages. We 
demonstrate that Hox11 function remains region-specific during postnatal development 
and regulates long bone growth through controlling chondrocyte maturation within the 
growth plate. 
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Materials and Methods 
Animals 
Male and female mice heterozygous for both the Hoxa11 and Hoxd11 null alleles 
and the Hoxa11eGFP knock-in allele were previously described [16, 81]. All procedures 
followed protocols reviewed and approved by the University of Michigan’s Committee 
on Use and Care of Animals.   
qPCR Analysis 
 Specimens were dissected in PBS on ice. Forelimbs/forelimb buds were removed 
and soft tissues were dissected away from the radius and ulna. The whole embryonic day 
(E) 12.5 limb bud or whole radius and ulna at E18.5, 1wk, 2wk and 4wk were collected 
into Trizol. Adult lung tissue was collected into Trizol as a control. qPCR for Hox11 
genes was performed with the following primer sets: Hoxa11F – 
CCTTTTCCAAGTCGCAATGT, Hoxa11R – AGGCTCCAGCCTACTGGAAT, 
Hoxd11F – AGTGAGGTTGAGCATCCGAG, Hoxd11R – 
ACACCAAGTACCAGATCCGC. Delta Ct values were calculated for each primer set 
relative to GAPDH at each time point assessed and normalized to expression in the adult 
lung which was set to ‘1’. Error bars represent standard deviation. A minimum of three 
animals were analyzed at each age. 
Histology, immunohistochemistry, in situ hybridization 
All specimens were dissected in PBS on ice. Right limbs were wrapped in PBS-
soaked gauze and stored at -20°C prior to µCT analysis. Left limbs were immediately 
processed for histology. For histological analyses, limbs were fixed for 3 days in 4% 
paraformaldehyde in PBS at 4°C and then decalcified in 14% EDTA for one week prior 
to embedding into OCT media. Newborn limbs did not require decalcification and were 
embedded in OCT immediately after fixation. Cryosections were collected at 16 µm 
through the radius/ulna.  
Endogenous Hoxa11eGFP expression at E18.5 was visualized without the use of 
an antibody, however the decalcification process results in high auto-fluorescence in 
adult tissues and an antibody against GFP was required to visualize expression at 2wk. 
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Immunohistochemical staining was performed by blocking with donkey serum and 
incubation with primary antibody against GFP (Invitrogen, A-11122, 1:200) overnight at 
4˚C. Secondary antibody was incubated at room temperature: donkey anti-rabbit 
alexafluor488 (Invitrogen, A21206, 1:1000). Section in situ hybridization was performed 
using 35S-labeled riboprobes using standard techniques [163]. Hoxd11 in situ probes were 
previously described [164]. 
For skeletal preparations, newborn animals were skinned and fixed in 95% 
ethanol. Fixed skeletons were stained in Alcian Blue (76% ethanol:20% acetic acid) at 
37°C for 48 hours, rinsed in 95% ethanol, treated with 1% KOH for 4-5 hours and stained 
with Alizarin Red in 2% KOH for 1 hour. Stained skeleton were cleared successively in 
20% glycerol:1% KOH, 50% glycerol:1% KOH and 100% glycerol. Forelimbs were 
removed and imaged on a Leica MZ125 stereo microscope (Buffalo Grove, IL, USA). 
To visualize growth plate morphology, cryosections were stained with Safranin-
O/Fast Green/Hematoxylin as previously described [165]. Images were captured on an 
Olympus BX-51 upright light microscope with an Olympus DP70 camera (Center Valley, 
PA, USA). Measurements of the total growth plate length were performed using ImageJ 
software [166].  
Micro-computed tomography (µCT) analysis 
Samples were scanned using an eXplore Locus SP microCT system (GE 
Healthcare, Pittsburgh, PA, USA). All specimens were scanned in water using the 
following parameters: voltage 80 kVp; current 80 µA; exposure time 1600 ms; voxel size 
in the reconstructed image 18 µm, isotropic. The data were processed and analyzed using 
MicroView (v 2.1.2 Advanced Bone Application; GE Healthcare Preclinical Imaging). 
First, the image was reoriented so that the anterior-posterior and longitudinal axes were 
aligned with the principal image axes. Next, the bone was manually segmented starting 
with a frame at the center of the bone and extending 72 µm on either side to identify a 
144 µm region of interest (ROI). The tissue mineral density (TMD), cortical area, cortical 
thickness, and inner and outer perimeters were calculated. The total length of the radius, 
ulna and humerus was measured along the central curvature of the bone. A minimum of 
five animals were analyzed at each age. 
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Bone histomorphometry 
 Five animals each of control and Hox11 compound mutant were injected with 
xylenol orange (90 mg/kg) (Sigma, St. Louis, MO, USA) , calcein (15 mg/kg) (Sigma, St. 
Louis, MO, USA), and alizarin complexone (30 mg/kg) (Sigma, St. Louis, MO, USA) in 
PBS at 2 weeks, 3 weeks and 4 weeks of age respectively. Animals were sacrificed two 
days following the final injection and limbs were collected. Un-decalcified bones were 
processed and embedded into plastic as previously published [167]. 200 µm thick 
sections were collected, mounted to plastic slides and polished to approximately 30 µm 
thickness. Images were captured at 20X magnification using a Zeiss Axiovert 200 M 
inverted microscope equipped with Apotome imaging system (Zeiss, Thornwood, NY, 
USA). 
BrdU incorporation 
 Timed pregnant females, 1 week, and 2 week pups were injected intraperitoneally 
with bromodeoxyuridine (100mg/kg)/fluorodeoxyuridine (12mg/kg) (Sigma, St. Louis, 
MO, USA) in DPBS. Pregnant females were sacrificed 2 hours after injection and 1 and 2 
week pups were sacrificed 4 hours after injection. Specimens were dissected in PBS on 
ice. Forelimbs were collected and the soft tissues were removed. Limbs were fixed for 3 
days in 4% paraformaldehyde in PBS at 4°C, decalcified in 14% EDTA for one week, 
and then washed into 70% ethanol prior to processing into paraffin. Microtome sections 
were collected at 7 µm through the radius/ulna. BrdU signal was visualized utilizing a 
BrdU immunostaining kit (Life Technologies, Grand Island, NY, USA). Total number of 
cells, as counted by Dapi positive nuclei, and BrdU-positive cells were counted using 
ImageJ software and proliferation rates were calculated as number of BrdU-positive cells 
divided by total number of cells. A minimum of three animals were analyzed at each age. 
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CHAPTER III 
Hox expressing cells serve as skeletal stem/progenitor cells 
throughout life  
Summary 
Multipotent mesenchymal stromal cells (MSCs) are necessary to support skeletal 
function throughout life, however, the lineage relationships between developmental 
progenitors and adult progenitors is unclear. Current models suggest distinct waves of 
progenitors, with postnatally arising adult MSCs replacing embryonic progenitors. We 
previously reported exclusive expression and function of the embryonic patterning 
transcription factor, Hox11, in adult skeletal progenitor-enriched MSCs. Here, using a 
Hoxa11-CreERT2 lineage-tracing system, we show Hox-expressing cells give rise to all 
skeletal lineages throughout life and persist as adult MSCs. Further, Hoxa11 lineage-
positive cells are capable of life-long self-renewal, even from embryonic stages. Hox11-
expressing cells additionally give rise to previously described progenitor-enriched MSC 
populations marked by LepR-Cre and Osx-CreER.  Our studies establish Hox-expressing 
cells as a life-long, skeletal stem cell population arising from the earliest stages of 
skeletal development. 
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Introduction 
Hox genes are well known for their roles in patterning the embryonic skeleton. 
Hox1 through Hox13 paralogs are expressed and function regionally along the anterior-
posterior axis of the axial skeleton, with the Hox9-Hox13 paralogs co-opted to also 
pattern along the proximal to distal axis of the appendicular skeleton [16, 21-23, 37]. The 
Hox11 paralogs pattern the sacral region of the spine and the zeugopod region of the limb 
(radius/ulna and tibia/fibula). Loss of Hox11 function during development results in 
dramatic mis-patterning of the zeugopod skeletal elements [16, 83]. In addition to 
developmental roles, compound Hox11 mutants exhibit defects in skeletal growth during 
postnatal stages and in adult fracture repair [108-110]. 
Despite clear genetic evidence for Hox function in the skeleton, Hox expression is 
excluded from all differentiated cell types at all stages, including chondrocytes and 
osteoblasts [80, 109, 110]. Embryonically, Hox11 expression is observed in the 
developing zeugopod perichondrium/periosteum immediately adjacent to Sox9-positive 
chondrocytes or Osterix-positive pre-osteoblasts [80]. At postnatal and adult stages, 
Hox11-expressing cells remain in the outer periosteal stroma adjacent to the osteoblast 
layer, and are additionally observed in the bone marrow and endosteal (inner) bone 
surface [109, 110]. Adult Hox11-expressing stromal cells from all skeletal compartments 
are exclusively identified by antibodies that mark progenitor-enriched mesenchymal 
stem/stromal cell (MSC) populations: PDGFRα/CD51 and Leptin-Receptor (LepR) [110, 
131, 132]. Hox-expressing cells also overlap with Leptin Receptor-Cre (LepR-Cre) 
lineage-labeled bone marrow MSCs [110, 132]. In vitro, Hox11 mutant MSCs are unable 
to differentiate into chondrogenic and osteogenic lineages indicating that Hox11 genes 
are functional within this population [110].  
The progenitor-enriched MSC population genetically marked by LepR-Cre 
contains the majority of bone marrow CFU-F activity and gives rise to most (61%-81%) 
osteoblasts and some (13%) osteocytes in cortical bone by 14 months of age [132]. 
Despite first appearing in the skeleton at late embryonic/early postnatal stages, LepR-Cre 
lineage-marked cells only begin to make a substantial contribution to the osteoblast 
lineage at 6 months of age, demonstrating this constitutive Cre does not mark progenitors 
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that support embryonic skeleton development or postnatal growth [132, 137]. A variety 
of genetic lineage-tracing models have been utilized to investigate the skeletal 
stem/progenitor potential of distinct cell populations throughout the life of the animal. 
Prx1-Cre lineage-marked lateral plate mesodermal cells contribute to all cells of skeleton 
during development and overlap with PDGFRα/Sca1 and LepR cells in adult bone 
marrow, providing evidence that MSC populations come from cells that arise from the 
lateral plate mesoderm [132, 134, 138, 168]. However, this genetic model is not inducible 
and broadly marks all limb mesenchyme. Thus, it is unclear when long-term progenitors 
arise or if there is a more specific population that constitutes embryonic skeletal 
progenitors. 
Several more recently published inducible Cre alleles revealed differences in 
lineage contribution of cells marked at embryonic or postnatal stages. Induction of Osx-
CreER lineage during embryonic stages demonstrates that these cells behave as skeletal 
progenitors during development and postnatal growth but are depleted by adult stages 
[137, 140]. Postnatal induction of Osx-CreER leads to labeling of a small proportion of 
long-lived bone marrow MSCs. [137, 140]. Embryonic induction of Gli1-CreERT2 
lineage marks perichondrial/periosteal cells that contribute to the skeleton and give rise to 
LepR-positive stromal cells up to 8-weeks of age however, this lineage was not reported 
at later stages [141]. Postnatal Gli1-CreERT2 lineage-marked cells only give rise to 
osteoblasts with no contribution to bone marrow MSCs or other skeletal lineages [141]. 
Postnatal induction of Gremlin1-CreER demonstrates lineage contribution to 
chondrocytes, osteoblasts, and bone marrow stromal cells out to 8 weeks [142]. In these 
studies, embryonically-induced Gremlin1-lineage contribution beyond newborn stages 
was not reported. Collectively, these data have led to a model that asserts the existence a 
primitive embryonic progenitor population that supports embryonic and postnatal skeletal 
development that is replaced by the establishment of a long-term adult MSC pool arising 
during postnatal life [117, 118].   
Previous work has genetically established the importance of Hox11 genes in 
embryonic skeletal development, postnatal growth, and adult fracture repair [80, 108-
110]. Given the continuity in Hoxa11eGFP expression in undifferentiated stromal cells 
throughout life and the recent identification of adult Hox11-expressing cells as skeletal 
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MSCs, we sought to test the progenitor capacity of the Hox11-expressing population 
throughout life [80, 110]. Using a Hoxa11-CreERT2 lineage-tracing allele, we find that 
Hoxa11-lineage marked cells continuously give rise to all the skeletal mesenchymal 
lineages (cartilage, bone, and fat) throughout life. By adult stages, Hoxa11-lineage 
marked stromal cells co-express MSC markers PDGFRα+/CD51+ and LepR+ and, in 
contrast to other reported genetically-marked progenitor populations, persist to at least 
one year of age even when lineage labeling is initiated at embryonic stages. Further, we 
demonstrate that Hoxa11-lineage marked MSCs continue to express Hoxa11eGFP at all 
stages examined, consistent with in vivo self-renewal of this population. To understand 
the lineage relationships between Hox11-expressing cells and other genetically marked 
progenitor/MSC populations from embryonic to adult stages, we compared Hoxa11eGFP 
expression to cells genetically marked by LepR-Cre and Osx-CreER [132, 137, 140]. We 
provide evidence that Hox11-expressing cells are upstream progenitors that give rise to 
the cells marked by the other genetic models. These data support that the Hox-expressing 
stromal cell population specifically enriches for skeletal mesenchymal stem cells and 
demonstrate the presence of a lineage-continuous MSC population from the earliest 
stages of skeleton development. 
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Results 
Hoxa11eGFP expression defines a continuous PDGFRα+/CD51+ population in the 
skeleton 
Hox11 expression is regionally-restricted in the limb to the embryonic zeugopod 
(radius/ulna and tibia/fibula) within the perichondrium surrounding the chondrocyte 
anlage and within the outer periosteum immediately adjacent to developing Osterix-
positive pre-osteoblasts at later stages [Figure 3.1A-B]. Throughout life, Hoxa11eGFP-
expressing cells persist on the periosteal surface, and are also observed on endosteal bone 
surfaces and as stromal cells within the bone marrow space from postnatal stages [Figure 
3.1C-F]. At adult stages, Hoxa11eGFP-expressing cells are exclusively identified by co-
expression of PDGFRα/CD51 and of LepR, cell surface markers for progenitor-enriched 
MSCs [110, 131, 132]. Consistent with the possibility that Hox11 expression defines 
skeletal mesenchymal progenitors throughout life, Hoxa11eGFP-expressing cells are 
observed in several regions that have been demonstrated to contain progenitors including 
the distal growth plate, the perichondrium/periosteum, and the trabecular bone. [Figure 
3.1A-F and [144, 169-171]].  
 We analyzed Hoxa11eGFP-expressing cells from embryonic, postnatal, and adult 
stages for co-expression of adult MSC markers PDGFRα/CD51 and LepR by flow 
cytometry. At embryonic stages, analyses were performed on the entire skeletal anlage, 
while at postnatal and adult stages, the bone marrow and bone adherent fractions were 
analyzed separately. PDGFRα/CD51 co-labels the majority of Hoxa11eGFP-expressing 
cells from embryonic stages out to one year of age [Figure 3.1G and Sup Figure 3.1]. In 
agreement with previous reports, LepR expression does not initiate until approximately 
newborn stages [Figure 3.5 and [132, 137]]. Consistent with increasing expression in 
stromal progenitors during postnatal life, co-expression of Hoxa11eGFP with LepR 
increases during this time; by adult stages the majority of Hox-expressing cells are LepR-
positive [Figure 3.1G and Sup Figure 3.1B]. While it has not been established whether 
adult MSC cell surface markers label progenitors during embryogenesis, these data 
demonstrate that Hoxa11eGFP-expressing stromal cells maintain a constant cell surface 
signature from when each marker is first expressed. 
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Figure 3.1: Skeletal Hoxa11eGFP expression defines a continuous PDGFRα/CD51 
population throughout life. (A-F) Hoxa11eGFP expression in the forelimb zeugopod 
(radius and ulna) shown from embryonic to adult stages. Hoxa11eGFP expression (green) 
in radius and ulna (A-C), with higher magnification image showing cartilage marker, 
Sox9 at E13.5 (A, red) and osteoblast marker, Osterix at E14.5 (B, magenta).  (D-F) mid-
diaphysis radius (r) and ulna (u) with proximal on left and distal on right (higher 
magnification images of mid-diaphysis ulna shown on right). In all images, grey: DAPI. 
Bone marrow: bm, periosteum: po, endosteum: endo (G) Flow cytometry analyses of 
whole skeletal anlage (E12.5, E14.5, and P0) or flushed bone marrow (P14, 8 week, 6 
month, and 1 year). Gating strategy and bone surface analyses shown in Sup Figure 3.1. 
Non-hematopoietic, non-endothelial stromal compartment (CD45-TER119-CD31-) was 
gated on PDGFRα/CD51 (top) or Leptin Receptor (LepR-Ab, bottom). Percentages 
reflect proportion of Hoxa11eGFP-positive population within double-positive gate (top) 
or bracketed region of histogram (bottom). Grey dots or grey histogram: total non-
endothelial stroma (NES), green dots or green histogram: Hoxa11eGFP-expressing non-
endothelial stroma (Hoxa11eGFP+). n=3-7 mice per group. All data presented as mean ± 
standard deviation. 
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Cas9/CRISPR generation of a Hoxa11-CreERT2 allele  
To rigorously examine the lineage potential of Hox11-expressing cells in vivo, we 
generated a tamoxifen inducible Cre knock-in at the Hoxa11 locus using Cas9/CRISPR 
mediated gene editing [Sup Figure 3.2A].  Briefly, two guide RNA sequences were 
designed to cut near the boundaries of exon 1 and a recombination plasmid was generated 
containing a tamoxifen-inducible Cre cassette (CreERT2) with the rabbit β-globin poly-
adenylation sequence [172]. This insertion cassette was flanked by 1.3kb of homology 
upstream and downstream of exon 1. The editing strategy resulted in replacement of exon 
1 with CreERT2, including a strong stop, while maintaining the endogenous Hoxa11 
upstream and surrounding sequences. Founder animals were screened by PCR for 
insertion of CreERT2 sequence [Sup Figure 3.2B]. Targeting to the Hoxa11 locus was 
validated by Southern Blot analyses using 5’ and 3’ flanking probes as well as an internal 
probe for CreER [Sup Figure 3.2C]. Hoxa11-CreERT2 mice were crossed to ROSA26-
LSL-tdTomato reporter mice and no tdTomato expression was observed in the absence of 
tamoxifen administration [Sup Figure 3.2D].  
Hoxa11-lineage marked cells contribute to all skeletal mesenchymal lineages 
throughout life 
The in vivo lineage potential of Hox11-expressing cells was assessed by 
generating mice that carried Hoxa11CreERT2;ROSA26-LSL-tdTomato to report lineage 
contribution to the skeleton in combination with a Hoxa11eGFP real-time reporter to 
determine if Hoxa11-lineage marked cells persist as Hox11-expressing MSCs [81]. 
Lineage-tracing was initiated by administering tamoxifen at E13.5, a time point at which 
embryonic Hoxa11eGFP expression has become restricted to the stromal population 
surrounding the developing zeugopod, but several days prior to the formation of a bone 
marrow cavity [Figure 3.1A and [80]]. Embryonic Hoxa11-lineage marked cells 
(Hoxa11E13.5) closely matched Hoxa11eGFP expression further confirming the integrity 
of the Hoxa11-CreERT2 allele [Figure 3.2A]. Two days after injection, at E15.5, the 
embryonic skeletal anlage has begun to mature, with cartilaginous growth plates on the 
distal ends and ossification initiating in the center of each element. Hoxa11E13.5-lineage 
marked cells are observed throughout the perichondrium/periosteum surrounding the  
54		
 
Figure 3.2: Hoxa11-lineage marked cells contribute to the zeugopod skeleton 
throughout life. Schematic of Hoxa11-CreERT2 allele. Exon 1 of Hoxa11 was replaced 
with CreERT2 followed by a rabbit β-globin poly-adenylation stop sequence (see 
materials and methods). Endogenous sequence in blue, edited sequence in red, start site 
marked by ‘ATG’. (A-H) Pregnant females were given 2mg of tamoxifen 
intraperitoneally at E13.5 and resulting Hoxa11eGFP;Hoxa11-CreERT2;ROSA-tdTomato 
animals were examined at indicated ages. Hoxa11 lineage-marked cells (Hoxa11iTom) 
are red, Hoxa11eGFP-expressing cells are green. Shown are complete (A-B, F) or distal 
radius (r) and ulna (u) (C-E) or distal diaphysis region of tibia (G-H). (A) right panel 
shows image overlaid with Hoxa11eGFP. 24 hours after tamoxifen induction tdTomato 
expression is dim and visualized using an anti-RFP antibody. (C) Co-expression of 
Hoxa11eGFP and Hoxa11iTom. (I-N) P3 pups were given 0.25mg of tamoxifen 
intragastrically and Hoxa11eGFP;Hoxa11-CreERT2;ROSA-tdTomato mice were 
examined at indicated ages. Shown are complete (I left, L), distal (I right) or mid-
diaphysis (J-K) radius and ulna, or distal region of tibia (M-N). (I-J) Right panel shows 
Hoxa11iTom with Hoxa11eGFP (F, L) Inset shows complete humerus. Region boxed 
with dashed white line shown magnified on right; view of mid-diaphysis ulna. Bone 
marrow: bm, periosteum: po, endosteum: endo. All images shown with distal end of bone 
to right. In all images, grey: DAPI. All scale bars = 200µm.  
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zeugopod elements and additionally within the growth plate and on the bony surfaces 
[Figure 3.2B]. Significant overlap of Hoxa11E13.5-lineage marked cells and Hoxa11eGFP-
expressing cells continues to be observed while the Hoxa11-lineage marked population 
has expanded [Figure 3.2C and Sup Figure 3.3A]. By E18.5, Hoxa11E13.5-lineage marked 
cells are observed throughout the zeugopod growth plate, within the primary spongiosa, 
and in the outer periosteal region [Figure 3.2D]. Hoxa11E13.5-lineage marked cells 
contribute to both chondrocytes and osteoblasts at E18.5, demonstrating that the Hox11-
expressing population marks multipotent skeletal progenitors that function during 
embryogenesis [Sup. Figure 3.3B]. 
Following the Hoxa11E13.5-lineage marked population after birth revealed lineage 
labeling throughout the periosteum, the endosteum, and within the now-established bone 
marrow space [Figure 3.2E]. This pattern of distribution continues to adult stages and 
extensive lineage-labeling is observed [Figure 3.2F]. Consistent with the regional 
expression of Hoxa11eGFP, Hoxa11E13.5-lineage marked cells only contribute to the 
zeugopod skeleton and no lineage-labeling is seen in the stylopod (humerus) and other 
regions that do not express Hox11, demonstrating that this progenitor is a regionally 
persistent stromal population [Figure 3.2F, inset and data not shown]. Remarkably, 
Hoxa11E13.5-lineage marked cells continue to show remarkably strong contribution to the 
skeleton as late as one year of age [Figure 3.2G-H]. 
Lineage-labeling was next performed beginning at postnatal stages, a time when 
other genetic models demonstrate contribution to long-lived stromal cells, to test whether 
Hox11-expressing stromal cells function similarly at this stage. Tamoxifen was 
administered at postnatal day 3 (P3) and contribution of Hoxa11 lineage-marked cells 
(Hoxa11P3) was examined. During the first days following tamoxifen administration, 
Hoxa11P3-lineage marked cells are observed within the reserve zone chondrocytes at the 
distal growth plate and on the periosteal, the endosteal, and the trabecular bone surfaces 
consistent with the pattern of Hoxa11eGFP expression [Figure 3.2I-J]. Following an 
eight-week chase, Hoxa11P3-lineage marked cells contribute extensively to the skeleton 
and are observed on periosteal and endosteal bone surfaces as well as throughout the 
bone marrow space. [Figure 3.2L]. Similar to E13.5 lineage-induction, Hoxa11P3-lineage 
marked cells give rise to the skeletal lineages within the zeugopod and lineage 
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contribution is not observed in the stylopod [Figure 3.2L, inset]. Hoxa11P3-lineage 
marked cells persist and continue to contribute to the skeleton through one year of age 
[Figure 3.2M-N]. Of note, lineage induction at postnatal stages looks indistinguishable 
from embryonic labeling, consistent with the Hox11-expressing population representing 
skeletal progenitors with equivalent capacity at both stages. 
Hox11-expressing cells become cartilage, bone, and adipose cells and are maintained 
as a continuous, self-renewing skeletal progenitor throughout life 
 To examine the contribution of Hoxa11-CreERT2 lineage cells to differentiated 
mesenchymal skeletal cell types, we performed co-labeling with markers for cartilage, 
bone, and adipose tissues. Hoxa11E13.5-lineage marked cells differentiate into 
chondrocytes within the growth plate, osteoblasts on the trabecular and endosteal bone 
surfaces, osteocytes embedded within the cortical bone, and to bone marrow adipocytes 
[Figure 3.3A]. Analysis out to one year of age shows that Hoxa11E13.5-linege marked 
cells continue to give rise to all skeletal lineages; osteoblasts, osteocytes, and bone 
marrow adipocytes [Figure 3.3B]. In adult mice, osteoblasts are reported to live for one 
month, therefore multiple rounds of osteoblast turnover will have occurred between 
E13.5 and 1 year of age [173, 174]. Additionally, bone marrow adiposity increases with 
age [175]. Thus, the presence of Hoxa11E13.5-linege marked osteoblasts and adipocytes at 
one year of age is consistent with continued contribution to newly differentiated cells, not 
simply the persistence of differentiated cells over time. 
 We next performed flow cytometry analyses on Hoxa11E13.5-linege marked 
stromal cells from the zeugopod bone marrow and bone surfaces to assess the identity of 
these cells. The majority of Hoxa11E13.5-linege marked stromal cells from both 
compartments were confined to the non-hematopoietic, non-endothelial stromal 
compartment (CD45-TER119-CD31-) [Figure 3.3C and Sup Figure 3.3C]. Adult, 
Hoxa11E13.5-linege marked bone marrow stromal cells specifically express MSC markers 
PDGFRα/CD51 and LepR, demonstrating that the embryonically labeled Hoxa11-
expressing cells give rise to an adult, progenitor-enriched MSCs that are maintained 
throughout life [Figure 3.3C]. Similar flow cytometry profiles are observed for 
Hoxa11E13.5-lineage marked cells that persist on the cortical bone surfaces, with the 
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Figure 3.3: Hoxa11-CreERT2 lineage-marked cells become cartilage, bone, and 
adipose cells and are maintained as a continuous, self-renewing skeletal progenitor 
throughout life. (A-D) Pregnant dams received 2mg tamoxifen intraperitoneally at E13.5 
and resulting Hoxa11eGFP;Hoxa11-CreERT2;ROSA-tdTomato mice were chased to (A, 
C-D) 8 weeks or (B) 1 year. (E) P3 pups were given 0.25mg tamoxifen intragastrically 
and Hoxa11eGFP;Hoxa11-CreERT2;ROSA-tdTomato mice were chased to 8 weeks. (A, 
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E) Hoxa11 lineage-labeled cells (Hoxa11iTom, red) and co-expression with markers for 
each differentiated cell type. Shown are chondrocytes with characteristic columnar 
morphology at distal end of growth plate, osteoblasts stained with Osterix (white) on 
trabecular (top) and endosteal bone (bottom), osteocytes within the cortical bone stained 
with SOST (green), and bone marrow adipocytes stained with Perilipin (green). Upper 
and lower boundaries of growth plate and periosteal and endosteal boundaries of cortical 
bone marked by dashed and dotted yellow lines, respectively, white boxed region of 
single osteocyte magnified to right (i), and single adipocyte (ii) magnified to right. (B)  
Hoxa11iTom, red and immunolabeling for osteoblasts (Osterix, white) on periosteal (po, 
top) and endosteal (eo, bottom) bone surfaces, osteocytes (SOST, green) in cortical bone, 
and adipocytes (Perilipin, green) in bone marrow. Periosteal and endosteal boundaries of 
cortical bone marked by dotted yellow line, white boxed region of osteocytes magnified 
to right, and single adipocyte (i) magnified to right. (C) Flow cytometry analyses of non-
hematopoietic, non-endothelial stromal compartment (CD45-TER119-CD31-) in bone 
marrow. First panel: Hoxa11 lineage-marked cells (x-axis: Hoxa11iTom), second panel: 
analysis of Hoxa11iTom positive gate (red) for Hoxa11eGFP expression, third panel: co-
expression analysis of PDGFRα/CD51, fourth panel: co-expression analysis of Leptin 
Receptor (LepR-Ab). Percentages reflect proportion of Hoxa11iTom population in 
identified gate. Grey dots: total non-endothelial stroma (NES), red dots: Hoxa11iTom. 
n=3-5 mice per group. All data presented as mean ± standard deviation. (D) Co-
expression of Hoxa11iTom (red) and Hoxa11eGFP (green) in bone marrow. In all 
images, grey or blue: DAPI. 
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majority of labeled bone surface cells co-expressing PDGFRα/CD51 and LepR as we 
have previously reported for real-time Hoxa11eGFP [Sup Figure 3.3E and [110]]. A 
majority of Hoxa11E13.5-lineage marked cells additionally co-express Hoxa11eGFP up to 
one year of age [Figure 3.3C-D and Sup Figure 3.3D-F]. Collectively these data provide 
evidence that the embryonic Hoxa11-expressing cell population gives rise to adult 
Hoxa11eGFP-expressing MSCs and persists throughout life. 
 The same analyses were performed on Hoxa11P3-lineage marked stromal cells 
where essentially identical results are observed. Hoxa11P3-lineage marked cells 
differentiate into all mesenchymal skeletal cell types, including chondrocytes, 
osteoblasts, osteocytes, and bone marrow adipocytes [Figure 3.3E]. Hoxa11P3-lineage 
marked cells also continue this contribution through one year of age [Sup Figure 4A]. 
Flow cytometry analyses on Hoxa11P3-lineage marked bone marrow and bone surface 
stromal cells following an eight-week chase demonstrate that Hoxa11P3-lineage marked 
cells are contained within the non-hematopoietic, non-endothelial stromal compartment 
and co-express progenitor-enriched MSC markers PDGFRα/CD51 and LepR in both the 
bone marrow and bone surface compartments [Sup Figure 3.4B-D]. Hoxa11P3-lineage 
marked cells also express Hoxa11eGFP in both compartments, again consistent with the 
Hox11-expressing stromal population containing skeletal MSCs [Sup Figure 3.4C-D]. 
Hoxa11-lineage marked cells contribute to regenerating cartilage and bone 
following fracture injury 
 To examine whether Hoxa11-lineage marked cells serve as progenitors in 
regeneration of the skeleton following injury, Hoxa11CreERT2;ROSA26-LSL-tdTomato 
animals were administered tamoxifen at E13.5 or at P3 to initiate lineage-labeling and the 
ulna was fractured at adult stages (8-10 weeks of age). Contribution to regenerating 
cartilage and bone was analyzed 10 days post-injury (10DPI). Hox11E13.5- and Hoxa11P3-
lineage marked cells expand in response to fracture and are observed throughout the 
callus [Figure 3.4A,D]. Apparent expansion of both the lineage-marked periosteal 
stromal compartment and lineage-marked the bone marrow stromal compartment is 
observed. Hoxa11-lineage marked cells give rise to both Sox9-positive chondrocytes 
within the cartilaginous regions of the callus and to Osx-expressing osteoblasts within the   
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Figure 3.4: The Hoxa11-lineage marked cells contribute to regenerating cartilage 
and bone following fracture injury. An ulnar fracture was performed at 8 weeks of age 
on Hoxa11-CreERt2;ROSA-tdTomato mice following tamoxifen dosing at (A-C) E13.5 – 
2mg intraperitoneally to pregnant female, or (D-F) P3 – 0.25mg intragastrically to pup. 
(A, D) Hoxa11 lineage-positive cells (Hoxa11iTom, red) are observed throughout the 
fracture callus 10 days post-injury (DPI). Expansion from bone marrow (bm) and 
periosteal (po) compartments is observed. Fracture line marked with dashed yellow line 
and cortical bone (cb) is labeled. Dashed white lines indicates regions visualized with 
antibodies for cartilage (Sox9, B, E) and bone (Osx, C, F). In all images, grey: DAPI. 
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woven bone regions of the callus [Figure 3.4B-C,E-F]. Contribution of Hoxa11-lineage 
marked cells to the regenerating skeletal tissues is qualitatively equivalent whether 
lineage-tracing was initiated at embryonic or postnatal stages, demonstrating that 
Hoxa11-positive cells from both stages label functional adult skeletal MSCs. 
Comparison of Hoxa11eGFP expressing cells to other MSC lineage populations 
A critical knowledge gap in the field is understanding of the relationships between 
various identified stromal populations. Significant differences exist in the lineage-
dynamics of these populations at different stages throughout life, yet it is not clearly 
understood why. We sought to establish the relationship between Hox11-expressing cells 
and previously reported MSC populations genetically labeled by LepR-Cre and Osx-
CreER using our Hoxa11eGFP real-time reporter crossed to LepR-Cre;ROSA26-LSL-
tdTomato mice or Osx-CreER;ROSA26-LSL-tdTomato mice. 
LepR-Cre lineage-marked cells first appear during late embryonic stages as rare 
cells within the primary spongiosa [Figure 3.5A and [132, 137]]. At this stage, 
Hoxa11eGFP-expressing cells are found throughout the periosteum and along the bone 
surfaces of the primary spongiosa. There is virtually no overlap between LepR-Cre 
lineage-marked cells and Hoxa11eGFP at early stages [Figure 3.5A, arrowheads]. The 
number of LepR-Cre lineage-marked cells increases with age. In the bone marrow, the 
overlap between Hoxa11eGFP and LepR lineage-marked cells progressively increases 
with age until, by 15 weeks, the majority Hoxa11eGFP-expressing bone marrow stromal 
cells are also LepR lineage-positive [Figure 3.5B-E and Sup Figure 3.5, [110]]. 
Interestingly, there is a population of Hoxa11eGFP-expressing cells on the outer 
periosteal surface that remains LepR-Cre lineage-negative at all stages examined [Figure 
3.5D’-E’]. Thus, the Hoxa11eGFP population progressively overlaps with LepR-lineage 
marked cells, consistent with LepR-lineage labeling continuing to initiate in Hox-positive 
cells [Figure 3.5F]. Differences in the overlap between the bone marrow and bone 
adherent populations reveal a unique Hox11-expressing population in the periosteum. 
Previous reports demonstrate Osx-lineage contribution to MSCs at postnatal but 
not embryonic stages. We induced Osx-lineage labeling in Hoxa11eGFP;Osx-
CreER;ROSA26-LSL-tdTomato animals at E13.5 or at P3 to compare these populations.  
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Figure 3.5: LepR-Cre lineage-marked cells progressively co-express in existing 
Hoxa11eGFP-expressing population in bone marrow; much less overlap in 
periosteum. Analysis of the co-expression of Hoxa11eGFP (green) and LepR-Cre 
lineage-marked cells (LepRiTom, red) in Hoxa11eGFP;LepR-Cre;ROSA-tdTomato mice. 
Percentages (yellow) reflect proportion of Hoxa11eGFP-positive cells that also express 
LepRiTom. Flow cytometry analyses shown in Sup Figure 3.5. (A) LepRiTom is first 
observed at late embryonic stages. (B-E’) High magnification view of mid-diaphysis of 
ulna, (B-E), cortical bone (B’-E’).  In all images; grey: DAPI. Data presented as mean ± 
standard deviation. n=3-5 mice per group. (F) Diagram of data at E18.5, 2 week, and 15 
week. 
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One day following tamoxifen administration at E13.5, embryonic Osx-lineage marked 
cells (OsxE13.5) are restricted to the inner periosteal, pre-osteoblast layer, while Hox11-
expressing cells are restricted to the outer periosteal layer with little to no overlap 
observed [Figure 3.6A]. Osx-CreER lineage induced at E13.5 also labels hypertrophic 
chondrocytes in the developing bone. The pattern of OsxE13.5-lineage marked cells is 
consistent with Osterix protein expression using an anti-Osterix antibody [Figure 3.1B]. 
By E18.5, OsxE13.5-lineage marked cells are observed throughout the primary spongiosa 
and minimal co-expression with Hoxa11eGFP is observed [Figure 3.6B (i), arrows]. 
Hoxa11eGFP-expressing cells and OsxE13.5-lineage marked cells continue to exhibit a 
mutually exclusive stratified expression pattern in the periosteum, with OsxE13.5-lineage 
marked cells in the inner pre-osteoblast layer and Hoxa11eGFP-expressing cells in an 
adjacent outer periosteal layer. [Figure 3.6B (ii)]. Minimal overlap of these populations is 
observed through adult stages [Figure 3.6C]. OsxE13.5-lineage marked cells are rare and 
represent only 2.7±0.3% of the total Hoxa11eGFP-expressing population [Figure 3.6E]. 
Flow cytometry analyses of the few bone marrow OsxE13.5-lineage marked cells shows 
74.0±3.4% of cells co-express PDGFRα/CD51 and 69.3±8.3% co-express Hoxa11eGFP 
[Figure 3.6C-E]. Virtually no OsxE13.5-lineage marked cells remain on the bone surfaces 
by adult stages, having presumably all differentiated into osteoblasts and osteocytes 
[Figure 3.6C (i)]. These data reveal Hoxa11eGFP-expressing perichondrial/periosteal 
population that is distinct from OsxE13.5-lineage marked cells. Further, these populations 
do not become overlapping with age, consistent with embryonic Osx-lineage labeled cells 
not being MSCs [Figure 3.6D]. 
The Hoxa11-lineage contribution to bone and the stratified periosteal expression 
pattern of Hoxa11eGFP and OsxE13.5-lineage marked cells led us to investigate whether 
Hox11-expressing stromal cells give rise to the population marked by Osx-CreER. 
Tamoxifen was administered to Hoxa11-CreERT2;ROSA-tdTomato reporters at E11.5 
(Hoxa11E11.5), two days prior to induction of Osterix expression in the developing 
skeleton, and the contribution of the Hox11E11.5-lineage marked cells was assessed at 
E18.5. Hoxa11E11.5-lineage-marked cells contribute extensively to the skeleton at E18.5, 
giving rise to many Osterix-positive osteoblasts within the cortical bone and primary 
spongiosa [Figure 3.6A and Sup Figure 3.6]. Comparable contribution to the osteoblast 
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lineage at birth is observed from Hoxa11E13.5 [compare Sup Figure 3.6B sup to Sup 
Figure 3.3B]. These data show that the Hox11-lineage arises before the Osx-CreER 
lineage, and that Hox11-expressing cells serve as progenitors that give rise to the 
osteoblast lineage. 
Consistent with the reported broader mesenchymal progenitor capacity of the 
postnatal Osx-lineage marked population (OsxP3), some overlap is observed between 
Hoxa11eGFP-expressing cells and OsxP3-lineage marked cells at this stage. Three days 
following tamoxifen administration, OsxP3-lineage marked cells are localized to the bone 
surfaces (periosteal, endosteal, and trabecular) [Figure 3.6F]. Hoxa11eGFP-expressing 
cells are also observed in the periosteum, but overlap with OsxP3-lineage marked cells is 
restricted to the innermost layer [Figure 3.6F (i)]. Hoxa11eGFP-expressing cells are 
already present at this stage throughout the bone marrow space and no co-expression with 
rare OsxP3-lineage marked bone marrow cells is observed [Figure 3.6F (ii), arrow]. 
Following an 8-week chase, OsxP3-lineage marked cells contribute to bone, fat, and bone 
marrow stromal cells, consistent with previous reports [Figure 3.6G and [137]]. Most 
OsxP3-lineage marked cells in the bone marrow co-express Hoxa11eGFP and progenitor-
enriched MSC markers PDGFRα/CD51 [Figure 3.6G-I]. On the bone surfaces, only 
about half of OsxP3-lineage marked cells co-express PDGFRα/CD51 and Hoxa11eGFP 
[Figure 3.6I]. The remaining population likely reflects lineage-marked cells actively 
undergoing osteoblast differentiation. Interestingly, the majority of overlap of 
Hoxa11eGFP-expressing cells and OsxP3-lineage marked cells is observed on the 
endosteal surface, while a stratified, non-overlapping expression pattern continues to be 
observed on the periosteal surface [Figure 3.6G (i)]. Of note, OsxP3-lineage marked cells 
represent only a small fraction of the total Hoxa11eGFP-expressing population, ~11% 
[Figure 3.6I]. These data show that Osx-CreER marks a sub-population of Hox11-
expressing MSCs at postnatal stages that persist to adult stages [Figure 3.6H]. These data 
additionally highlight a unique Hox11-expressing population in the outer periosteum, 
adjacent to the Osx-positive inner pre-osteoblast periosteal layer that does not overlap 
with Osx-lineage marked cells at any stage. 
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Figure 3.6: Hoxa11eGFP-expressing MSCs are distinct from embryonic Osx-CreER 
lineage-marked cells; postnatal Osx-CreER lineage-marked cells only marginally 
overlap in bone marrow and do not overlap in outer periosteum. Comparison of 
Hoxa11eGFP (green) and Osx-CreER lineage-marked cells (OsxiTom, red) was 
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performed in Hoxa11eGFP;Osx-CreER;ROSA-tdTomato mice. (A-E) Pregnant females 
received 2mg tamoxifen intraperitoneally at E13.5 and co-expression of Hoxa11eGFP 
and embryonic Osx-lineage was examined at (A) E14.5, (B) E18.5 and (C, E) 8 weeks. 
(A) Complete radius (r) and ulna (u) 24 hours after tamoxifen with proximal to the left 
and distal to the right. High magnification of region marked by dashed white line 
(below). Periosteum: po (B) Mid-diaphysis ulna; below, high magnification image of 
primary spongiosa (i) and periosteum (ii). (C) Mid-diaphysis ulna; on right, high 
magnification images of (i) endosteum (endo) and (ii) bone marrow (bm). Cortical bone: 
cb. (D) Diagrammatic representations of data. (E) Flow cytometry analysis of non-
hematopoietic, non-endothelial stroma (CD45-TER119-CD31-, NES) in bone marrow 
(left panels) and bone adherent (right panels) compartments. First panel: analysis of 
OsxiTom population for PDGFRα/CD51, second panel: analysis of OsxiTom for 
Hoxa11eGFP, third panel: analysis of Hoxa11eGFP-positive cells (green) for OsxiTom 
expression. OsxiTom cells are very rare (0.018±0.03 of total NES) on bone surface (left 
panels) and do not express Hoxa11eGFP. (F-I) P3 pups were given 0.25 mg tamoxifen 
intragastrically and co-expression of Hoxa11eGFP and postnatal Osx-lineage was 
examined at (F) P6 and (G-H) 8 weeks. (F) Mid-diaphysis ulna, high magnification 
images (below) of cortical bone (i) and bone marrow (ii), rare OsxiTom stromal cell 
(arrow). (G) Mid-diaphysis tibia, high magnification images (right) of periosteum (i) and 
bone marrow (ii). (H) Diagrammatic representations of data. (I) Flow cytometry analysis 
of non-hematopoietic, non-endothelial stroma (CD45-TER119-CD31-) in bone marrow 
(left panels) and bone surface (right panels) compartments. First panel: analysis of 
OsxiTom population for PDGFRα/CD51, second panel: analysis of OsxiTom for 
Hoxa11eGFP, third panel: analysis of Hoxa11eGFP-positive cells (green) for OsxiTom 
expression. All fluorescent images, grey: DAPI. Flow cytometry dot plots, grey dots: 
total non-endothelial stroma (NES). n=3-5 mice per group. Data presented as mean ± 
standard deviation. 
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Discussion 
 Previous lineage-tracing analyses have supported a model whereby transient, 
embryonic skeletal progenitor populations are later replaced with bona fide adult skeletal 
stem cells arising during early postnatal life [117, 118]. A substantial caveat to many of 
the genetic tools used in previous analyses is that tamoxifen-inducible Cre expression is 
driven by promoters for genes that function in early lineage commitment to skeletal cell 
types (chondrocyte – Sox9-CreER, or osteoblast – Osx-CreER), for instance [137, 140] 
[reviewed by [143]]. Therefore, the bulk of Sox9-CreER lineage-marked cells will be 
committed to the chondrocyte fate and the bulk of Osx-CreER lineage-marked cells to the 
osteoblast fate, while only a small population of putative progenitors that perhaps did not 
fully commit to differentiation are likely to be marked by these alleles. Labeling of long-
term skeletal progenitors with these alleles is non-specific and incomplete, and temporal 
differences in MSC capacity observed likely reflects exhaustion of early committed 
progenitors over time. A subset of genetic models, driven by promoters of genes involved 
in key signaling pathways such as Hedgehog (Gli1-CreER) or BMP (Gremlin1-CreER), 
also demonstrate temporal differences in progenitor capacity over time [141, 142]. 
Hedgehog and BMP signaling are both critically important pathways in chondrogenic and 
osteogenic differentiation [176-178]. Differences in the progenitor capacity of these 
lineage-marked populations may reflect changes in the signaling environment of the 
skeleton with age. These caveats collectively suggest that the proposed waves of skeletal 
progenitors may be an artifact of the genetic models and not a physiologically relevant 
property of skeletal MSCs. 
Prior reports establish Hox expression is excluded from differentiated skeletal cell 
types at all stages and genetically demonstrate Hox gene function in the skeleton 
throughout life [80, 108-110].  Further, real-time expression of Hoxa11eGFP marks only 
progenitor-enriched MSCs and no other differentiating cell types. Herein, we present 
evidence that the Hox11-expressing stromal population, marked by Hoxa11-CreERT2 
from both embryonic and postnatal stages, specifically enriches for a population of 
skeletal stem cells throughout the life of the animal and are likely to represent the true 
MSC compartment.  In contrast to models suggesting developmental progenitors are later 
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replaced by postnatally arising, long-lived adult MSCs, these data reveal a lineage-
continuous skeletal MSC population throughout life from embryonic stages. Hoxa11 
lineage-marked cells contribute extensively to the skeleton, giving rise to all skeletal cell 
types including chondrocytes, osteoblasts, osteocytes, and bone marrow adipocytes at all 
stages examined. Further, Hoxa11 lineage-marked cells expand and contribute to 
regenerating cartilage and bone following fracture injury. In addition to contributing to 
differentiated skeletal cells, Hoxa11 lineage-marked cells persist within the bone marrow 
space and on the cortical bone surfaces throughout life and maintain co-express MSC 
markers PDGFRα/CD51 and LepR. The majority of lineage-marked stromal cells 
additionally express Hoxa11eGFP, establishing a continuous lineage relationship 
between the embryonic and the adult Hox11-expressing skeletal progenitor population. 
The collective data establishing the contribution of Hoxa11 lineage-marked cells to the 
skeleton and the persistence of Hoxa11 lineage-marked stromal cells at all stages 
provides in vivo evidence that the Hox11-expressing stromal population enriches for life-
long skeletal MSCs. 
Assessing the relationship between different genetically defined populations of 
skeletal progenitors is critical for understanding how these populations behave and can 
provide information on the spatiotemporal dynamics of skeletal stem cells throughout 
life. Hoxa11-CreERT2 lineage-tracing data demonstrates that Hox11-positive progenitors 
arise days prior to the appearance of Osx-CreER lineage-marked cells (around E13.5) or 
LepR-Cre (around E17.5). In all of these comparative analyses, there is consistently a 
unique Hox-expressing population in the periosteum that does not overlap with the Osx- 
or LepR-lineage marked cells after short- or long-term lineage-tracing. The periosteal 
compartment has been shown to contain skeletal stem cells with greater capacity to 
regenerate bone compared to bone marrow MSCs, suggesting this unique Hox-positive 
population may represent the true skeleton stem cell [179]. Embryonic Osx-lineage 
marked cells only function as progenitors transiently, and little to no overlap is observed 
with Hoxa11eGFP-expressing cells, consistent with these populations being entirely 
distinct. In contrast, postnatal Osx-lineage marked cells give rise to a small population of 
long-lived stromal cells. Shortly following postnatal induction of the Osx-lineage marked 
cells, overlap of Hoxa11eGFP-expressing cells and Osx-lineage marked cells is observed 
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on the bone surfaces while a unique Hoxa11eGFP-expressing cell population remains on 
the outer periosteum and within the bone marrow. By adult stages, only a fraction of 
Hoxa11eGFP-expressing bone marrow MSCs are Osx lineage-marked, however most 
Osx lineage-marked cells overlap with Hoxa11eGFP-expression. These data are 
consistent with Hox-expressing progenitors in the outer periosteum giving rise to the 
population marked by Osx-CreER, and thereby the complete osteo-lineage, and suggests 
a temporal window during development and early postnatal life where the bone marrow 
stroma is likely established from cells within the periosteum. 
We also show that Hox11-expressing MSCs are progressively LepR-lineage-
marked with time and, by adult stages, the majority of Hoxa11eGFP-expressing, 
progenitor-enriched MSCs overlap with the LepR-lineage marked cells. Given LepR-Cre 
is not a temporally controlled Cre, these data suggest that LepR expression, and thus the 
LepR-Cre, is increasingly initiated within the Hoxa11eGFP-expressing population 
beginning around birth. Interestingly, LepR-Cre progressively marks Hoxa11eGFP-
expressing bone marrow progenitors more rapidly and more completely than 
Hoxa11eGFP-expressing cells within the bone adherent compartment. LepR-Cre lineage 
labeling in the bone adherent (endosteal and periosteal) compartment correlates with the 
onset of LepR-lineage marked cell contribution to bone [132, 137]. These data lead to 
speculation that LepR-Cre is expressed only gradually, and perhaps never completely, 
within the true skeletal mesenchymal stem cell population. Together, our comparative 
studies provide strong evidence that Hox-positive MSCs give rise to Osx-CreER and 
LepR-Cre lineage-marked populations and establish a unique Hox-expressing periosteal 
origin for skeletal stem cells. 
Rux, et al. reported that adult bone marrow MSCs from different anatomical 
regions display a Hox expression profile consistent with regionally-restricted expression 
domains established during embryonic development [110]. Hoxa11-CreERT2 allows for 
the unique labeling of a zeugopod-restricted MSC population and shows that skeletal 
contributions of MSCs remain regional throughout life. Together, these data provide 
strong support for a model whereby regional, Hox-expressing stem cell populations in the 
skeleton are established during embryonic development and give rise to regionally-
restricted mesenchymal stem cells that function throughout life. It is increasingly 
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important to understand whether differences in the Hox expression profile in MSCs from 
different skeletal regions results in functionally distinct stem cell populations. This could 
have critical implications for the optimal therapeutic and tissue engineering use of bone 
marrow MSCs.  
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Supplemental Information 
 
 
 
Supplemental Figure 3.1: Bone adherent Hoxa11eGFP-expressing cells express 
MSC markers PDGFRα/CD51 and Leptin Receptor. (A) Gating strategy to obtain 
non-hematopoietic, non-endothelial stromal compartment. Example from adult (8-10wk) 
bone marrow. (B) Compliment to Figure 3.1G, flow cytometry analyses of bone adherent 
compartment (P14, 8 week, 6 month, and 1 year). Non-hematopoietic, non-endothelial 
stromal compartment (CD45-TER119-CD31-) was gated on PDGFRα/CD51 (top) or 
Leptin Receptor (LepR-Ab, bottom). Percentages reflect proportion of Hoxa11eGFP-
positive population within double positive gate (top) or bracketed region of histogram 
(bottom). Grey dots or grey histogram: total non-endothelial stroma (NES), green dots or 
green histogram: Hoxa11eGFP-expressing non-endothelial stroma (Hoxa11eGFP+). n=3-
5 mice per group. All data presented as mean ± standard deviation. 
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Supplemental Figure 3.2: Cas9/CRISPR generation of a Hoxa11-CreERT2 allele: (A) 
Schematic of Cas9/CRISPR targeting of Hoxa11 locus for generation of Hoxa11-
CreERT2 allele. Top: Hoxa11 locus, positions and sequence of sgRNAs (grey box: PAM), 
Nco1 restriction sites, positions for 5’ and 3’ Southern Blot probes and size of wild-type 
(WT) fragment generated. Middle: Hoxa11-CreERT2 targeting vector, 5’ and 3’ 
homology regions (thick black line), CreERT2 and rabbit globin poly-adenylation (PA) 
insertion (red), and location of Cre PCR primers. Bottom: Hoxa11-CreERT2 allele, Nco1 
restriction sites, positions for 5’, 3’ and Cre Southern Blot probes and size of edited 
fragments generated. (B) PCR analysis for Cre sequence on 29 live births. (C) Southern 
Blot on four Cre-positive animals using 5’ probe (top), 3’ probe (middle) and Cre probe 
(bottom). Wild-type and edited bands and sizes as marked. (D) CreERT2 recombination in 
the absence of tamoxifen in Hoxa11-CreERT2;ROSA-tdTomato mice at 6 weeks of age. 
Fluorescent image - red: Hoxa11 lineage-marked cells (Hoxa11iTom), grey: DAPI. 
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Supplemental Figure 3.3: Embryonic Hoxa11 lineage-marked cells contribute to all 
skeletal lineages during development and give rise to self-renewing skeletal MSCs 
on the bone surface. Pregnant dams received 2mg tamoxifen intraperitoneally at E13.5 
and resulting Hoxa11eGFP;Hoxa11-CreERT2;ROSA-tdTomato mice were chased to (A) 
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E16.5, (B) E18.5 (C-E) 8 weeks or (F) 1 year. (A) Hoxa11eGFP (green) expression and 
lineage contribution of Hoxa11 lineage-marked cells (Hoxa11iTom, red) in forelimb 
(humerus (h), radius (r), and ulna (u)). Compliment to Figure 2C. (B) High magnification 
view of ulna growth plate from Figure 2D. Dashed white boxes show approximate 
location of high magnification images (below). Co-expression of Hoxa11iTom and 
Osterix (white) in (i) primary spongiosa (ii) periosteum (po). (C) Flow cytometry 
analyses of Hoxa11iTom cells in the hematopoietic (top, CD45+TER119+) and 
endothelial (bottom, CD45-TER119-CD31+) compartments in the bone marrow. 
Percentages reflect proportion of Hoxa11iTom population in indicated gate. Data 
presented as mean ± standard deviation. n=3-5 mice per group (D) Co-expression of 
Hoxa11iTom and Hoxa11eGFP on the bone surface. Cortical bone: cb, bone marrow: 
bm, dashed white line marks endosteal (endo) bone surface. (E) Flow cytometry analysis 
of non-hematopoietic, non-endothelial stromal compartment (CD45-TER119-CD31-) on 
bone surface, compliment to Figure 3.3C. Top left panel: Hoxa11-lineage (x-axis: 
Hoxa11iTom), top right panel: analysis of Hoxa11iTom by Hoxa11eGFP, bottom left 
panel: co-expression analysis of PDGFRα/CD51, bottom right panel: co-expression 
analysis of Leptin Receptor (LepR-Ab). Percentages reflect proportion of Hoxa11iTom 
population within identified gate. Grey dots: total non-endothelial stroma (NES), red 
dots: Hoxa11iTom. n=3-5 mice per group. All data presented as mean ± standard 
deviation. (F) Hoxa11eGFP in Hoxa11iTom bone marrow stromal cells after one year 
chase. All images, grey or blue: DAPI. 
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Supplemental Figure 3.4: Postnatal Hoxa11 lineage-marked cells contribute to all 
skeletal lineages and give rise to self-renewing skeletal MSCs. P3 pups received 
0.25mg tamoxifen intragastrically and Hoxa11eGFP;Hoxa11-CreERT2;ROSA-tdTomato 
mice were chased to (A) 1 year or (B-C) 8 weeks. (A) Hoxa11 lineage-marked cells 
(Hoxa11iTom, red) and immunolabeling for osteoblasts (Osterix, white) on endosteal 
bone surface, osteocytes (SOST, green) in cortical bone, and adipocytes (Perilipin, green) 
in bone marrow. All images, grey: DAPI (B) Flow cytometry analyses of Hoxa11iTom 
cells in the hematopoietic (left, CD45+TER119+) and endothelial (right, CD45-TER119-
CD31+) compartments in the bone marrow. Percentages reflect proportion of 
Hoxa11iTom population within gate. Data presented as mean ± standard deviation. n=3-5 
mice per group. (C) Hoxa11iTom and Hoxa11eGFP (green) in bone marrow (left) and on 
bone surface (right). Bone marrow: bm, cortical bone: cb, white dashed lines mark 
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periosteal and endosteal (endo) surfaces. All images, blue or grey: DAPI (D) Flow 
cytometry analyses of non-hematopoietic, non-endothelial stromal compartment (CD45-
TER119-CD31-) in bone marrow (top) or on bone surface (bottom). First panel: Hoxa11-
lineage (x-axis: Hoxa11iTom), second panel: analysis of Hoxa11iTom positive gate for 
Hoxa11eGFP, third panel: co-expression analysis of PDGFRα/CD51, fourth panel: co-
expression analysis of Leptin Receptor (LepR-Ab). Grey dots: total non-endothelial 
stroma (NES), red dots: Hoxa11iTom. Percentages reflect proportion of Hoxa11iTom 
population in marked gate. n=3-5 mice per group. All data presented as mean ± standard 
deviation. 
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Supplemental Figure 3.5: Hoxa11eGFP-expressing population progressively 
overlaps with LepR-Cre lineage-marked cells. Compliment to Figure 3.5. Flow 
cytometry analyses of Hoxa11eGFP-expressing stromal cells (green) and LepR-Cre 
lineage (LepRiTom) in whole bone at P0, or bone marrow (top) and bone adherent 
(bottom) compartments from P14 to 15 weeks. Analysis in non-hematopoietic, non-
endothelial (CD45-TER119-CD31-) compartment. Percentages reflect proportion of 
Hoxa11eGFP-positive population within indicated gate. n=3-5 mice per group. All data 
presented as mean ± standard deviation. 
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Supplemental Figure 3.6: Induction of Hoxa11-CreERT2 at E11.5 leads to lineage-
marked Osterix-positive osteoblasts in zeugopod. Pregnant dams received 2mg 
tamoxifen intraperitoneally at E11.5 and resulting Hoxa11-CreERT2;ROSA-tdTomato 
mice were chased to E18.5. (A) Hoxa11 lineage-marked cells (Hoxa11iTom, red) within 
complete radius and ulna. White dashed line marks region shown in B. Grey: DAPI. (B) 
Hoxa11iTom and immunostaining for osteoblasts (Osterix, white) in mid-diaphysis ulna. 
To right, high magnification images of boxed regions in (i) primary spongiosa and (ii) 
periosteum (po). Blue: DAPI.	
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Methods 
Mouse models 
 All mice were maintained in a C57BL/6 background. Hoxa11eGFP [81], Leptin 
Receptor-Cre [180], Osterix-CreERT2 [170] mice have been described elsewhere. 
Rosa26-CAG-loxp-stop-loxp-tdTomato ([181], JAX stock #007909) were obtained from 
Jackson Laboratory.  Both male and female mice were used for experiments. Animals 
were euthanized for experiments through CO2 exposure followed by removal of a vital 
organ. All procedures described here were conducted in compliance with the University 
of Michigan’s Committee on Use and Care of Animals, protocol PRO00006651 (Wellik) 
and protocol PRO00006763 (Goldstein). 
Generation of Hoxa11-CreERT2 mice 
Production of sgRNAs and Cas9 mRNA: 
 Two guide sequences targeting exon 1 of Hoxa11 were designed and cloned into 
the pT7-Guide Vector (Blue Heron Biotech, LLC). The guide sequence and approximate 
locations of both sgRNAs, including the corresponding PAM sequence, are illustrated in 
Sup Figure 2A. MEGAshortscript T7 kit (Life Technologies) was used to generate in 
vitro transcribed sgRNAs from the pT7-Guide Vector and products were subsequently 
purified using the MEGAclear kit (Life Technologies). Using the pT7-Cas9-Nuclease 
vector (gift from Dr. Moises Mallo), Cas9 mRNA was in vitro transcribed using the 
mMESSAGE mMACHINE T7 ULTRA kit (Life Technologies) and purified using the 
MEGAclear kit (Life Technologies). 
Production of targeting plasmid: 
 Homologous sequence flanking exon 1 of Hoxa11 were synthesized by Blue 
Heron Biotech, LLC into the pUCminusMCS vector as a continuous insert separated by 
sequence containing restriction sites for EcoRI, NotI, and HindIII to allow for sub-
cloning of CreERT2 and rabbit β-globin poly-adenylation signal. The 5’ homology arm 
contained 1.3kb immediately upstream of the endogenous Hoxa11 start site and 3’ 
homology arm contained 1.3kb of sequence immediately downstream of sgRNA 2 as 
illustrated in Sup Figure 2A. Sequence for CreERT2 and rabbit β-globin poly(A) signal 
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was sub-cloned from pCAG-CreERT2 vector (gift from Connie Cepko, Addgene plasmid 
#14797, [172]). Targeting of CreERT2 to Hoxa11 locus preserves endogenous upstream 
and downstream sequence and creates a null allele; expressing CreERT2 in place of 
Hoxa11. 
Zygote injection and confirmation of targeting: 
 Zygote injections were performed as previously described with minor 
modifications [182]. C57BL/6 female mice were superovulated and mated with C57Bl/6 
male mice and one-cell stage embryos were collected for microinjection. CRISPR 
reagents were microinjected at the following concentrations: Cas9 mRNA (100ng/µL), 
each sgRNA (50ng/µL), and targeting plasmid (20ng/µL). Freshly injected eggs were 
transferred into pseudopregnant females and resulting progeny were initially screened for 
potential CreERT2 insertion via PCR. The following internal primers for CreER sequence 
were used: Cre Fwd: 5’ GGACATGTTCAGGGATCGCCAGGC 3’, Cre Rev: 5’ 
CGACGATGAAGCATGTTTAGCTG 3’. Approximate location of primers indicated in 
Sup Figure 2A. Cre-positive animals by PCR were analyzed by Southern Blotting to 
confirm targeting using 5’ and 3’ flanking probes and a Cre internal probe with Nco1 
digested DNA. Approximate locations of probes are illustrated in Sup Figure 2A. The 
453 bp 5’ probe was generated using primers: 5’ TTTCGGTTCTCCTAGACGCC 3’ and 
5’ CACGGCGTTTGCATGAGATT 3’, the 533 bp 3’ probe was generated using primers: 
5’ TCTGTAGTGAGCGCCTTTGG 3’ and 5’ GAGGTTCCCGAGAGACTCCT 3’, and 
the 408 bp Cre probe was generated using primers: 5’ 
GCATTACCGGTCGATGCAACGAGTGATGAG 3’ and 5’ 
GAGTGAACGAACCTGGTCGAAATCAGTGCG 3’, that were randomly labeled with 
32P-dCTP. Four animals were CreER positive via PCR and three animals showed correct 
targeting via Southern Blot [Sup Figure 2B-C]. Animal #27 displayed germline 
transmission of the allele. Animals from this founder were used in all subsequent 
experiments. 
Tamoxifen treatment 
 For embryonic induction, Hoxa11-CreERT2 or Osx-CreERT2 male mice were 
mated to RosatdTomato/tdTomato or Hoxa11eGFP;ROSAtdTomato/tdTomato female mice and the 
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vaginal plug was checked every morning. Pregnant mice received 2mg of tamoxifen 
(Sigma T5648) and 1mg/mL progesterone (Sigma P0130) dissolved in corn oil 
intraperitoneally at indicated embryonic day. For postnatal induction, pups of the 
genotype indicated in figures received 0.25mg of tamoxifen intragastrically at P3. At 
least three embryos, pups, or adult animals of the indicated genotypes were examined at 
time points shown in figures. 
Ulnar fracture 
 Following procedure previously described in detail [108, 110]. Tamoxifen was 
administered as described above, and animals were aged to adult stages (8-10 weeks). 
Briefly, animals were anesthetized with isoflurane during procedure and provided 
buprenorphine pre- and postoperatively and carprofen during recovery period. A small 
incision was made along the posterior ulnar surface and the bone was exposed via blunt 
dissection. Using fine wire cutters, the ulna was cut at the mid-shaft. Skin was closed 
using sutures. Animals were euthanized for analysis at 10 days post injury. At least three 
animals from each tamoxifen induction time point were examined. 
Immunohistochemistry 
 Limb skeletal tissues were collected at the indicated ages or time point following 
fracture injury. All specimens were dissected in PBS on ice and skin was removed prior 
to fixation for postnatal and adult tissues. Samples were fixed in 4% paraformaldehyde in 
PBS (embryo: 1-3 hours, postnatal (P3-P7): 4-6 hours, adult (2wk+): 1-2 days) rocking at 
4°C. Postnatal and adult tissues were decalcified in 14% EDTA for 1-7 days depending 
on age. Samples were equilibrated in 30% sucrose overnight prior to embedding into 
optimal cutting temperature medium. Cryosections were collected at 12-30 µm through 
indicated segments of the limb or fracture callus using the Kawamoto tape method [183]. 
Immunohistochemical staining was performed using standard methods. Sections 
were blocked with donkey serum and incubated with primary antibodies overnight at 4°C 
against Sox9 (Millipore, AB5535, 1:500), Osterix (Abcam, ab22552, 1:300), and 
Perilipin (Sigma, P1873, 1:100). Secondary antibodies were incubated at room 
temperature for 2 hr: donkey-anti-rabbit-Alexa Fluor 647 (Thermo Fisher, A31573, 
1:1000) and donkey-anti-rabbit-Alexa Fluor 488 (Thermo Fisher, A21206, 1:1000). A 
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modified signal amplification protocol was used to visualize SOST. Following blocking, 
primary antibody against SOST (R&D Systems, AF1589, 1:100) was incubated overnight 
at 4°C followed by donkey-anti-goat-biotin secondary (Jackson ImmunoResearch, 705-
067-003, 1:400). The biotinylated secondary was detected using Vectastain Elite ABC kit 
(Vector Laboratories, PK-6100) and signal was amplified by Alexa Fluor 488 Tyramide 
reagent (Thermo Fisher, B40853). To minimize imaging complications from 
autofluorescence in postnatal and adult tissues, Hoxa11eGFP was visualized using 
chicken-anti-GFP (Abcam, ab13970, 1:2000) and donkey-anti-chicken-Alexa Fluor 488 
(Invitrogen, A11039, 1:1000) in combination with aforementioned antibodies. tdTomato 
expression was dim at 24-72hr post-tamoxifen induction and was visualized using rabbit-
anti-RFP (Rockland, 600401379, 1:1000) and donkey-anti-rabbit-Alexa Fluor 555 
(Invitrogen, A31572, 1:1000). Following longer chases, tdTomato was imaged directly 
without the use of an antibody. 
 Fluorescent images were captured on an Olympus BX-51 microscope with an 
Olympus DP-70 camera or Leica Upright Sp5x 2-photon confocal microscope. Confocal 
z-stacks were obtained through entire sections at a thickness of 2 µm and images were 
stacked using ImageJ software. When applicable, 10x images were stitched together 
using Photoshop software to obtained images of entire limbs and fracture calluses. 
Flow cytometry analysis 
 Bone marrow cells were harvested by flushing the marrow cavity with digestion 
buffer (2 mg/mL collagenase IV and 3 mg/mL dispase in 1X PBS) using a 30G needle for 
both the radius and ulna. To obtain bone adherent cells, the remaining bone following 
bone marrow flushing was minced in digestion buffer and subjected to subsequent 
digestion. The digestion of all samples was carried out at 37°C with three rounds of 
agitation to achieve a single cell suspension. After each cycle of digestion/agitation, cells 
in suspension were collected into media (DMEM, 5% calf serum) and kept at 37°C until 
the entire digestion protocol was finished. Red blood cells were lysed on ice using lysis 
buffer at a final concentration of 0.5X. For staining, cells were resuspended in staining 
buffer (1X PBS, 0.5% BSA, 2mM EDTA) at a concentration of 1 x 106 cells/30µl in a 
solution containing the following antibodies. For hematopoietic exclusion: CD45-AF700 
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(eBioscience, clone 30-F11, 1:100) and TER119-APC-Cy7 (Becton Dickinson, clone 
TER119, 1:100). For endothelial cell exclusion: CD31-PerCPCy5.5 (Becton Dickinson, 
clone MEC13.3, 1:100). For MSC identification: PDGFRα/CD140a-APC (eBioscence, 
clone APA5, 1:100) and biotinylated rat-anti-CD51 (Biolegend, clone RMV-7, 1:100) or 
biotinylated goat-anti-leptin receptor (R&D, BAF497, 1:50) and streptavidin-Brilliant 
Violet 605 (Biolegend, 405229, 1:500). Following staining on ice, all samples were 
washed twice with staining buffer and resuspended in staining buffer containing DAPI 
(1:10,000) for analysis. All analyses were carried out on an LSRII Fortessa flow 
cytometer (BD) and results were analyzed with FlowJo (v10.2) software. Results are 
presented as mean values ± standard error of the mean (SEM). No statistical method was 
used to predetermine sample size. Sample size was determined on the basis of previous 
literature and our previous experiments to give sufficient standard error of the mean, and 
feasible generation of experimental animals. The experiments were not randomized and 
investigators were not blinded during experiments and assessment of results.  
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CHAPTER IV 
Interaction of Hox11, Ihh, Runx2, and Wnt5a in early limb 
development 
Summary 
 Long bone growth is driven by chondrocyte proliferation and differentiation 
within highly organized structures at the distal ends of the bone termed the growth plate. 
Numerous signaling pathways and transcription factor networks function both 
cooperatively and in parallel to regulate chondrocyte proliferation differentiation to effect 
proper bone growth. The Hox transcription factors regulate skeletal patterning during 
development. Loss-of-function of the Hox11 paralogs results in dramatic mispatterning of 
the zeugopod skeletal elements characterized by significantly short elements composed of 
immature and disorganized chondrocytes. Loss-of-function of the Hedgehog pathway 
ligand Indian hedgehog (Ihh), the Wnt ligand Wnt5a, or the transcription factor Runx2 
results in skeletal phenotypes that are remarkably similar to Hox11 mutants suggesting 
potential functional relationships between Hox11 and one or more of these factors. We 
show that expression of Ihh, Runx2, and Wnt5a is reduced or absent in Hox11 mutants 
during early skeletal development. Using a Gli1-lacZ reporter allele we show that Hox11-
expressing perichondrial cells respond to Hedgehog signaling, and that Hox11 mutants 
display dramatically reduced levels of Gli1-lacZ signal. Interestingly, in an ex vivo limb 
culture system, activation of the Hedgehog pathway using a pharmacologic Smoothened 
agonist demonstrates that Hox11 mutant cells are capable of responding to Hedgehog 
signaling. These studies provide preliminary evidence suggesting a relationship between 
Hedgehog signaling and Hox11 function in the skeleton.  
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Introduction 
 Long bones of the appendicular skeleton form through the process of 
endochondral ossification whereby a cartilaginous template is first established and is 
progressively replaced by bone. In the limb bud, Sox9-expressing chondrocyte 
progenitors condense along the proximal to distal axis of the limb to form the skeletal 
anlage with the stylopod containing one element (humerus or femur), the zeugopod 
containing two elements (radius/ulan or tibia/fibula), and the autopod containing many 
elements (carpals/metacarpals and tarsals/metatarsals) [52-55]. At the borders of the 
condensations, a layer of elongated fibroblasts, the perichondrium, forms surrounding the 
cartilage template [184]. This tissue is thought to provide mechanical cues to control the 
ratio of lengthwise to girthwise growth of the skeletal elements. Longitudinal bone 
growth is driven by the highly ordered processes of chondrocyte proliferation and 
differentiation. All chondrocytes of the skeletal anlage are initially highly proliferative. 
As the element grows in size, chondrocytes at the center of the anlage stop proliferating, 
undergo hypertrophic differentiation, and switch from secreting a type II collagen matrix 
to a type X collagen matrix [185]. Signaling from the hypertrophic chondrocytes to the 
perichondrium initiates osteoblast differentiation of the adjacent perichondrial cells and 
invasion of blood vessels and chondroclasts/osteoclasts to digest the hypertrophic matrix 
and initiate formation of the bone marrow cavity [170, 184, 186]. Chondrocyte 
proliferation and differentiation continues at the distal ends of the bones in highly 
organized structures termed the growth plate [148]. 
 The posterior Hox genes (Hox9-13) function regionally to pattern the limb 
skeleton along the proximal to distal axis. The mutant phenotypes resulting from 
paralogous loss-of-function mutations in these genes are well described, however the 
mechanism of Hox function during early skeletal development and patterning continue to 
be largely unknown [187]. Hox11 genes pattern the zeugopod region of the limb and 
complete loss-of-function mutations of the Hox11 paralogs results in significant mis-
pattering of this region [16, 80, 83]. Early specification of the elements is unaffected in 
these mutants. Sox9-expressing chondrogenic progenitors condense normally, forming 
two skeletal anlagen in the zeugopod that express a type II collagen matrix by embryonic 
